<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">World J Transplant</journal-id><journal-id journal-id-type="publisher-id">WJT</journal-id><journal-title-group><journal-title>World Journal of Transplantation</journal-title></journal-title-group><issn pub-type="epub">2220-3230</issn><publisher><publisher-name>Baishideng Publishing Group Inc</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7109593</article-id><article-id pub-id-type="other">jWJT.v10.i3.pg47</article-id><article-id pub-id-type="doi">10.5500/wjt.v10.i3.47</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Emerging and neglected zoonoses in transplant population</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mrzljak</surname><given-names>Anna</given-names></name><aff>Department of Medicine, Merkur University Hospital, Zagreb 10000, Croatia</aff><aff>School of Medicine, University of Zagreb, Zagreb 10000, Croatia. <email>anna.mrzljak@mef.hr</email></aff></contrib><contrib contrib-type="author"><name><surname>Novak</surname><given-names>Rafaela</given-names></name><aff>School of Medicine, University of Zagreb, Zagreb 10000, Croatia</aff></contrib><contrib contrib-type="author"><name><surname>Pandak</surname><given-names>Nenad</given-names></name><aff>Depatment of Medicine, The Royal Hospital Muscat, Muscat 111, Oman</aff></contrib><contrib contrib-type="author"><name><surname>Tabain</surname><given-names>Irena</given-names></name><aff>Department of Virology, Croatian Institute of Public Health, Zagreb 10000, Croatia</aff></contrib><contrib contrib-type="author"><name><surname>Franusic</surname><given-names>Lucija</given-names></name><aff>General Hospital Dubrovnik, Dubrovnik 20000, Croatia</aff></contrib><contrib contrib-type="author"><name><surname>Barbic</surname><given-names>Ljubo</given-names></name><aff>Department of Microbiology and Infectious Diseases with Clinic, Faculty of Veterinary Medicine, University of Zagreb, Zagreb 10000, Croatia</aff></contrib><contrib contrib-type="author"><name><surname>Bogdanic</surname><given-names>Maja</given-names></name><aff>Department of Virology, Croatian Institute of Public Health, Zagreb 10000, Croatia</aff></contrib><contrib contrib-type="author"><name><surname>Savic</surname><given-names>Vladimir</given-names></name><aff>Poultry Center, Croatian Veterinary Institute, Zagreb 10000, Croatia</aff></contrib><contrib contrib-type="author"><name><surname>Mikulic</surname><given-names>Danko</given-names></name><aff>Department of Abdominal and Transplant Surgery, Merkur University Hospital, Zagreb 10000, Croatia</aff></contrib><contrib contrib-type="author"><name><surname>Pavicic-Saric</surname><given-names>Jadranka</given-names></name><aff>Department of Anesthesiology and Intensive Medicine, Merkur University Hospital, School of Medicine, University of Zagreb, Zagreb 10000, Croatia</aff></contrib><contrib contrib-type="author"><name><surname>Stevanovic</surname><given-names>Vladimir</given-names></name><aff>Department of Microbiology and Infectious Diseases with Clinic, Faculty of Veterinary Medicine, University of Zagreb, Zagreb 10000, Croatia</aff></contrib><contrib contrib-type="author"><name><surname>Vilibic-Cavlek</surname><given-names>Tatjana</given-names></name><aff>Department of Virology, Croatian Institute of Public Health; School of Medicine, University of Zagreb, Zagreb 10000, Croatia</aff></contrib></contrib-group><author-notes><fn><p>Author contributions: Mrzljak A and Vilibic-Cavlek T made contributions to conception and design of the study, involved in drafting and revising the manuscript critically; Novak R, Pandak N, Tabain I, Franusic L, Bogdanic M, Barbic L, Savic V, Mikulic D, Pavicic-Saric J and Stevanovic V were involved in collecting data and drafting the manuscript; all authors read and approved the final manuscript.</p><p>Corresponding author: Anna Mrzljak, FEBG, MD, PhD, Associate Professor, Department of Medicine, Merkur University Hospital, Zajceva 19, Zagreb 10000, Croatia. <email>anna.mrzljak@mef.hr</email></p></fn></author-notes><pub-date pub-type="ppub"><day>31</day><month>3</month><year>2020</year></pub-date><pub-date pub-type="epub"><day>31</day><month>3</month><year>2020</year></pub-date><volume>10</volume><issue>3</issue><fpage>47</fpage><lpage>63</lpage><history><date date-type="received"><day>22</day><month>12</month><year>2019</year></date><date date-type="rev-recd"><day>15</day><month>3</month><year>2020</year></date><date date-type="accepted"><day>22</day><month>3</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9;The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/"><license-p>This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.</license-p></license></permissions><abstract><p>Zoonoses represent a problem of rising importance in the transplant population. A close relationship and changes between human, animal and environmental health (&#x0201c;One Health&#x0201d; concept) significantly influence the transmission and distribution of zoonotic diseases. The aim of this manuscript is to perform a narrative review of the published literature on emerging and neglected zoonoses in the transplant population. Many reports on donor-derived or naturally acquired (re-)emerging arboviral infections such as dengue, chikungunya, West Nile, tick-borne encephalitis and Zika virus infection have demonstrated atypical or more complicated clinical course in immunocompromised hosts. Hepatitis E virus has emerged as a serious problem after solid organ transplantation (SOT), leading to diverse extrahepatic manifestations and chronic hepatitis with unfavorable outcomes. Some neglected pathogens such as lymphocytic choriomeningitis virus can cause severe infection with multi-organ failure and high mortality. In addition, ehrlichiosis may be more severe with higher case-fatality rates in SOT recipients. Some unusual or severe presentations of borreliosis, anaplasmosis and rickettsioses were also reported among transplant patients. Moreover, toxoplasmosis as infectious complication is a well-recognized zoonosis in this population. Although rabies transmission through SOT transplantation has rarely been reported, it has become a notable problem in some countries. Since the spreading trends of zoonoses are likely to continue, the awareness, recognition and treatment of zoonotic infections among transplant professionals should be imperative.</p></abstract><kwd-group><kwd>Zoonoses</kwd><kwd>Solid-organ transplant</kwd><kwd>Vector-borne diseases</kwd><kwd>Non-vector borne diseases</kwd><kwd>Viruses</kwd><kwd>Bacteria</kwd><kwd>Parasites</kwd></kwd-group></article-meta></front><body><p><bold>Core tip:</bold> The importance of zoonotic diseases in the transplant population is rising. Given the current diversity and extent of zoonotic pathogens, modes of transmission and clinical presentation in immunocompromised hosts, this manuscript aims to summarize the published literature on emerging and neglected zoonoses in the transplant population.</p><sec><title>INTRODUCTION</title><p>Zoonotic diseases - transmitted and shared between animals and humans, are nowadays receiving increased recognition. WHO estimates that more than 60% of all human pathogens are zoonotic, and that they represent 75% of all emerging pathogens during the past decade[<xref rid="B1" ref-type="bibr">1</xref>]. They encompass a wide range of pathogens (viruses, bacteria, parasites) and modes of transmission: <italic>via</italic> direct contact with infected animals or their secretions, the bite of arthropod vectors or indirect contact <italic>via</italic> the environment[<xref rid="B2" ref-type="bibr">2</xref>]. Given a close relationship between human, animal and environmental health (the &#x0201c;One Health&#x0201d; concept), human activities, climate and landscape changes influence significantly transmission and distribution of zoonoses[<xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B4" ref-type="bibr">4</xref>]. The number of zoonotic diseases has been increasing in the last two decades and the spreading trends are likely to continue in future years. For example, West Nile virus (WNV), one of the most widely distributed arboviruses has expanded its area of circulation in many European countries[<xref rid="B5" ref-type="bibr">5</xref>]. In 2018, a large outbreak occurred across Southern and Central Europe with the number of confirmed human cases increasing up to 7.2-fold from the previous transmission season[<xref rid="B6" ref-type="bibr">6</xref>]. A total of 2083 human cases and 285 outbreaks among equids were reported, including previously virus-free regions[<xref rid="B7" ref-type="bibr">7</xref>]. In addition, geographical distribution of Zika virus (ZIKV) has steadily expanded. In 2015 and 2016, large outbreaks of ZIKA occurred in the Americas. In the USA and US Territories, 5168 and 36512 symptomatic ZIKV disease cases were reported in 2016[<xref rid="B8" ref-type="bibr">8</xref>]. Hepatitis E virus (HEV) is an important cause of acute viral hepatitis worldwide, with an increasing incidence in Europe since 2010. The reported incidence over 10 years has grown by ten times: From 514 cases in 2005 to 5617 cases in 2015[<xref rid="B9" ref-type="bibr">9</xref>]. On the other hand, solid-organ transplant (SOT) population is expanding as a result of increasing transplant rates, improved post-transplant management and survival[<xref rid="B10" ref-type="bibr">10</xref>,<xref rid="B11" ref-type="bibr">11</xref>]. In comparison to immunocompetent hosts, immunocompromised state of SOT recipients is an inevitable additional risk for the infection and unfavorable outcomes due to atypical presentation, possible delay in diagnostic tests (serology), more frequent presence of disseminated/advanced disease and prolonged treatment. Although majority of zoonotic infections develop in the post-transplant period, donor or transfusion transmitted zoonotic infections have been increasingly acknowledged as well. Therefore, the increasing trend of reports on zoonotic diseases in the transplant population over the past decade substantiates a need for a comprehensive review. This narrative review will cover two main groups of zoonotic infections; vector and non-vector borne infections and focus on major pathogens and their clinical manifestations in the transplant population (Table <xref rid="T1" ref-type="table">1</xref>).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Clinical manifestations of emerging and neglected zoonoses in non-transplant and transplant population</p></caption><table frame="hsides" rules="groups"><thead align="center"><tr><td rowspan="2" align="left" colspan="1"><bold>Pathogen</bold></td><td colspan="2" rowspan="1"><bold>Clinical presentation</bold><hr/></td><td rowspan="2" colspan="1"><bold>Laboratory diagnosis</bold></td><td rowspan="2" colspan="1"><bold>Ref</bold>.</td></tr><tr><td rowspan="1" colspan="1"><bold>Immunocompetent patients</bold></td><td rowspan="1" colspan="1"><bold>Immunocompromised patients</bold></td></tr></thead><tbody align="center"><tr><td colspan="5" align="left" rowspan="1">Vector-borne zoonoses</td></tr><tr><td align="left" rowspan="1" colspan="1">Tick-borne encephalitis virus</td><td rowspan="1" colspan="1">Asymptomatic infection to severe encephalitis</td><td rowspan="1" colspan="1">Few data: One cluster of fatal TBE</td><td rowspan="1" colspan="1">ELISA (IgM, IgG), Avidity; VNT; RT-PCR</td><td rowspan="1" colspan="1">[<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B14" ref-type="bibr">14</xref>-<xref rid="B16" ref-type="bibr">16</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Borrelia burgdorferi</italic></td><td rowspan="1" colspan="1">Erythema migrans, arthritis, peripheral neuropathy, acrodermatitis chronica atrophicans, neuroborreliosis</td><td rowspan="1" colspan="1">Possible dissemination with severe neurological and cardiac symptoms</td><td rowspan="1" colspan="1">ELISA (IgM, IgG); IFA (IgM, IgG); Immunoblot (IgM, IgG); PCR</td><td rowspan="1" colspan="1">[<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B18" ref-type="bibr">18</xref>-<xref rid="B20" ref-type="bibr">20</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Anaplasma phagocytophilum</italic></td><td rowspan="1" colspan="1">Mostly self-limiting disease, non-specific symptoms, rash, gastrointestinal and CNS involvement</td><td rowspan="1" colspan="1">Unusual presentations: Acute respiratory distress syndrome, haemorrhagic manifestations, pancreatitis, acute renal failure, orchitis</td><td rowspan="1" colspan="1">Microscopy of peripheral blood (morulae); IFA (seroconversion of 4-fold increase in IgG titer); PCR</td><td rowspan="1" colspan="1">[<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B26" ref-type="bibr">26</xref>,<xref rid="B32" ref-type="bibr">32</xref>,<xref rid="B33" ref-type="bibr">33</xref>,<xref rid="B43" ref-type="bibr">43</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Ehrlichia</italic> spp.</td><td rowspan="1" colspan="1">Self-limiting febrile illness to fatal multi-organ failure</td><td rowspan="1" colspan="1">More frequently severe manifestations: Fatal multiorgan failure, acute respiratory distress syndrome meningoencephalitis, toxic and septic-like syndromes</td><td rowspan="1" colspan="1">Microscopy of peripheral blood (morulae); IFA (seroconversion of 4-fold increase in IgG titer); PCR</td><td rowspan="1" colspan="1">[<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B25" ref-type="bibr">25</xref>,<xref rid="B36" ref-type="bibr">36</xref>,<xref rid="B37" ref-type="bibr">37</xref>,<xref rid="B42" ref-type="bibr">42</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Rickettsia</italic> spp.</td><td rowspan="1" colspan="1">Self-limiting disease, flu-like symptoms, with or without eschar and rash; vasculitis-mediated organ failure</td><td rowspan="1" colspan="1">Few data: More frequently severe manifestations, splenic rupture</td><td rowspan="1" colspan="1">IFA (IgM, IgG); PCR</td><td rowspan="1" colspan="1">[<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B49" ref-type="bibr">49</xref>,<xref rid="B51" ref-type="bibr">51</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Orientia tsutsugamushi</italic></td><td rowspan="1" colspan="1">Nonspecific febrile illness to fatal multiorgan failure, eschar, CNS involvement</td><td rowspan="1" colspan="1">Few data: Only one case with eschar and renal graft dysfunction</td><td rowspan="1" colspan="1">IFA (IgM, IgG); PCR</td><td rowspan="1" colspan="1">[<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B53" ref-type="bibr">53</xref>,<xref rid="B54" ref-type="bibr">54</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Rift Valley Fever virus</td><td rowspan="1" colspan="1">Subclinical to severe febrile illness, fatal haemorrhagic fever</td><td rowspan="1" colspan="1">Few data: Only one case with meningoencephalitis</td><td rowspan="1" colspan="1">ELISA (IgM, IgG); VNT; RT-PCR</td><td rowspan="1" colspan="1">[<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B59" ref-type="bibr">59</xref>,<xref rid="B61" ref-type="bibr">61</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">St. Louis encephalitis virus</td><td rowspan="1" colspan="1">Majority asymptomatic, febrile illness, aseptic meningitis and encephalitis</td><td rowspan="1" colspan="1">Few data: Meningoencephalitis</td><td rowspan="1" colspan="1">ELISA (IgM, IgG); VNT; RT-PCR</td><td rowspan="1" colspan="1">[<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B63" ref-type="bibr">63</xref>,<xref rid="B65" ref-type="bibr">65</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Zika virus</td><td rowspan="1" colspan="1">Asymptomatic infection to severe neurological disorders</td><td rowspan="1" colspan="1">Infectious complications and graft rejection</td><td rowspan="1" colspan="1">ELISA (IgM, IgG); VNT; RT-PCR</td><td rowspan="1" colspan="1">[<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B69" ref-type="bibr">69</xref>-<xref rid="B71" ref-type="bibr">71</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Chikungunya virus</td><td rowspan="1" colspan="1">Mild febrile illness and polyarthralgia, rarely meningoencephalitis, myocarditis</td><td rowspan="1" colspan="1">No impact on graft function</td><td rowspan="1" colspan="1">ELISA (IgM, IgG); VNT; RT-PCR</td><td rowspan="1" colspan="1">[<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B74" ref-type="bibr">74</xref>,<xref rid="B75" ref-type="bibr">75</xref>,<xref rid="B77" ref-type="bibr">77</xref>,<xref rid="B79" ref-type="bibr">79</xref>,<xref rid="B80" ref-type="bibr">80</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Dengue virus</td><td rowspan="1" colspan="1">Asymptomatic infection to severe fatal illness</td><td rowspan="1" colspan="1">More commonly prolonged course with complications and graft rejection</td><td rowspan="1" colspan="1">ELISA (IgM, IgG); VNT; NS1 antigen; RT-PCR</td><td rowspan="1" colspan="1">[<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B82" ref-type="bibr">82</xref>,<xref rid="B84" ref-type="bibr">84</xref>-<xref rid="B86" ref-type="bibr">86</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">West Nile virus</td><td rowspan="1" colspan="1">Asymptomatic infection, mild febrile disease, neuroinvasive disease (elderly)</td><td rowspan="1" colspan="1">Fatal neuroinvasive disease more frequent</td><td rowspan="1" colspan="1">ELISA (IgM, IgG); VNT; Avidity; VNT; RT-PCR</td><td rowspan="1" colspan="1">[<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B87" ref-type="bibr">87</xref>,<xref rid="B96" ref-type="bibr">96</xref>,<xref rid="B97" ref-type="bibr">97</xref>,<xref rid="B108" ref-type="bibr">108</xref>,<xref rid="B109" ref-type="bibr">109</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Usutu virus</td><td rowspan="1" colspan="1">Asymptomatic infection, neuroinvasive disease (elderly)</td><td rowspan="1" colspan="1">Fatal neuroinvasive disease more frequent</td><td rowspan="1" colspan="1">ELISA (IgM, IgG); VNT; RT-PCR</td><td rowspan="1" colspan="1">[<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B114" ref-type="bibr">114</xref>-<xref rid="B119" ref-type="bibr">119</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Eastern equine encephalitis virus</td><td rowspan="1" colspan="1">Asymptomatic, neuroinvasive disease (meningitis, encephalitis)</td><td rowspan="1" colspan="1">Few data: Neuroinvasive disease</td><td rowspan="1" colspan="1">ELISA (IgM, IgG); VNT; RT-PCR</td><td rowspan="1" colspan="1">[<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B123" ref-type="bibr">123</xref>,<xref rid="B124" ref-type="bibr">124</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Leishmania</italic> spp.</td><td rowspan="1" colspan="1">Cutaneous, mucocutaneus and visceral leishmaniasis</td><td rowspan="1" colspan="1">The same as in immunocompetent; organomegaly may be less frequent in visceral leishmaniasis</td><td rowspan="1" colspan="1">Microscopy; Culture; PCR; IFA (IgM, IgG)</td><td rowspan="1" colspan="1">[<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B129" ref-type="bibr">129</xref>,<xref rid="B130" ref-type="bibr">130</xref>]</td></tr><tr><td colspan="5" align="left" rowspan="1">Non-vector-borne zoonoses</td></tr><tr><td align="left" rowspan="1" colspan="1">Hepatitis E virus</td><td rowspan="1" colspan="1">Asymptomatic infection, fulminant hepatitis, acute-on-chronic liver failure, extrahepatic manifestations</td><td rowspan="1" colspan="1">Chronic hepatitis, cirrhosis, extrahepatic manifestations</td><td rowspan="1" colspan="1">ELISA (IgM, IgG); Immunoblot (IgM, IgG); RT-PCR</td><td rowspan="1" colspan="1">[<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B131" ref-type="bibr">131</xref>-<xref rid="B133" ref-type="bibr">133</xref>,<xref rid="B135" ref-type="bibr">135</xref>,<xref rid="B136" ref-type="bibr">136</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Rabies virus</td><td rowspan="1" colspan="1">Fatal encephalitis</td><td rowspan="1" colspan="1">Fatal encephalitis</td><td rowspan="1" colspan="1">Microscopy (Negri bodies); DFA (antigen detection); IHC (antigen detection); RT-PCR, RFFIT, FAVN</td><td rowspan="1" colspan="1">[<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B143" ref-type="bibr">143</xref>-<xref rid="B146" ref-type="bibr">146</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Lymphocytic choriomeningitis virus</td><td rowspan="1" colspan="1">Asymptomatic infection, nonspecific febrile illness, aseptic meningitis</td><td rowspan="1" colspan="1">More severe clinical presentation, hepatitis, meningoencephalitis, multiorgan failure</td><td rowspan="1" colspan="1">ELISA (IgM, IgG); IFA (IgM, IgG); RT-PCR</td><td rowspan="1" colspan="1">[<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B99" ref-type="bibr">99</xref>,<xref rid="B151" ref-type="bibr">151</xref>,<xref rid="B152" ref-type="bibr">152</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Toxoplasma gondii</italic></td><td rowspan="1" colspan="1">Asymptomatic, mononucleosis-like symptoms</td><td rowspan="1" colspan="1">More severe clinical presentation, cerebral toxoplasmosis, fatal disseminated disease</td><td rowspan="1" colspan="1">ELISA (IgM, IgG); IFA (IgM, IgG); Avidity, Immunoblot (IgM, IgG); PCR</td><td rowspan="1" colspan="1">[<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B156" ref-type="bibr">156</xref>-<xref rid="B158" ref-type="bibr">158</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>CNS: Central nervous system; DFA: Direct immunofluorescence assay; ELISA: Enzyme-linked immunosorbent assay; FAVN: Fluorescent antibody virus neutralization test; IFA: Indirect immunofluorescence assay; IgG: Immunoglobulin G; IgM: Immunoglobulin M; IHC: Immunohistochemistry; NS1: Non-structural protein 1; PCR: Polymerase chain reaction; RT-PCR: Reverse-transcriptase polymerase chain reaction; TBE: Tick-borne encephalitis; RFFIT: Rapid fluorescent focus inhibition test; VNT: Virus neutralization test.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>VECTOR-BORNE ZOONOSES</title><sec><title>Tick-borne encephalitis virus</title><p>Tick-borne encephalitis virus (TBEV) is a tick-borne flavivirus widely distributed from Europe through far-eastern Russia to Japan. The virus is maintained in cycles involving <italic>Ixodid</italic> ticks (<italic>Ixodes ricinus</italic> and <italic>Ixodes persulcatus</italic>) and wild vertebrate hosts (mainly rodents)[<xref rid="B12" ref-type="bibr">12</xref>]. Transmission to humans occurs most commonly through a bite of an infected tick, however approximately 1% of all TBE cases are thought to be caused by food-borne TBEV (consumption of raw goat milk)[<xref rid="B13" ref-type="bibr">13</xref>,<xref rid="B14" ref-type="bibr">14</xref>]. TBEV can cause a wide spectrum of the disease, ranging from asymptomatic infection to severe encephalitis and even death[<xref rid="B14" ref-type="bibr">14</xref>]. Diagnosis is usually confirmed by the detection of TBEV IgM and IgG antibodies in serum and cerebrospinal fluid (CSF) samples. Determination of IgG avidity may be helpful in cases of atypical antibody response[<xref rid="B15" ref-type="bibr">15</xref>]. There are very few data on the transplant-transmitted TBEV infection. In 2012, a cluster of fatal TBEV infection was reported in Poland. Transmission of TBEV occurred through the transplanted organs (liver, kidneys) from a single donor to three recipients. The donor lived in an endemic area and the presence of TBEV was confirmed by the same viral strain detected in all recipients and in the donor[<xref rid="B16" ref-type="bibr">16</xref>]. Although transmission of TBEV through organ transplantation is rare, clinicians should consider screening donors who live or have recently visited endemic areas for TBEV, particularly during the arbovirus transmission season.</p></sec><sec><title>Borrelia burgdorferi (Lyme disease)</title><p><italic>Borrelia burgdorferi</italic> is a tick-borne zoonosis widely distributed in North America and Europe. All three pathogenic species, <italic>B. burgdorferi</italic>, <italic>B. afzelii</italic> and <italic>B. garinii</italic> occur in Europe, and the latter two have been identified in Asia. <italic>Borrelia burgdorferi</italic> circulates between <italic>Ixodes</italic> ticks and vertebrate hosts in an enzootic cycle. Ticks can transmit borrelia to humans, but humans are dead-end hosts, unlikely to continue the life cycle of the spirochete[<xref rid="B17" ref-type="bibr">17</xref>]. Lyme disease (LD) has a broad spectrum of clinical manifestations. Primary infection presents as erythema migrans (EM). Late stages occur weeks to years following infection and include arthritis, peripheral neuropathy, and skin &#x0fb01;ndings such as acrodermatitis chronica atrophicans[<xref rid="B18" ref-type="bibr">18</xref>]. Neuroborreliosis is one of the manifestations of LD involving the central nervous system (CNS)[<xref rid="B19" ref-type="bibr">19</xref>]. The role of immunosuppression in the development and progression of LD is not well understood. An analysis of SOT recipients on immunosuppressive treatment who presented with solitary EM did not reveal any signi&#x0fb01;cant differences in the clinical course of infection as compared with the general population[<xref rid="B20" ref-type="bibr">20</xref>]. The first case of LD in a transplanted patient was described in 1993 in a kidney transplant recipient in whom the disease progressed into the disseminated stage with severe neurological signs[<xref rid="B21" ref-type="bibr">21</xref>]. A study from Slovenia presented a case series of six SOT recipients with EM. All six patients had solitary skin lesions with clinical characteristics comparable to those of the skin lesions in immunocompetent patients. No clinical signs or symptoms suggesting borrelia dissemination were present or were reported either during the initial course of the illness or during the one-year follow-up period after antibiotic treatment and persistence of borrelia organisms in the skin after treatment was not established[<xref rid="B20" ref-type="bibr">20</xref>]. A case report of Lyme carditis after liver transplant that progressed to disseminated illness with a concomitant heart block and deterioration of mental status has also been described[<xref rid="B22" ref-type="bibr">22</xref>].</p></sec><sec><title>Anaplasma phagocytophilum (Human granulocytic anaplasmosis)</title><p>Human granulocytic anaplasmosis (HGA) is a tick-borne infection caused by <italic>Anaplasma phagocytophilum</italic>, an intracellular bacterium, which commonly infects neutrophils[<xref rid="B23" ref-type="bibr">23</xref>]. The infection is mostly spread through a bite of <italic>Ixodes</italic> ticks in Europe (<italic>Ixodes ricinus</italic> and <italic>Ix. persulcatus</italic>) and in North America (<italic>Ix. scapularis</italic> and <italic>Ix. pacificus</italic>) after feeding on infected animals such as domestic (dog, horse) and wild ruminants, hedgehogs and wild boars[<xref rid="B24" ref-type="bibr">24</xref>,<xref rid="B25" ref-type="bibr">25</xref>]. However, there are reports of transmission through infected blood as well as of perinatal transmission[<xref rid="B25" ref-type="bibr">25</xref>]. Immunocompetent individuals with HGA develop high-grade fever, malaise, nausea, headache, myalgia, arthralgia, CNS and gastrointestinal symptoms. Rarely individuals present with an erythematous rash[<xref rid="B26" ref-type="bibr">26</xref>]. Whereas anaplasmosis is mostly a self-limiting disease, predictors of a more severe course include advanced age, immunosuppression, and comorbidities such as diabetes[<xref rid="B26" ref-type="bibr">26</xref>]. Severe course includes the development of acute respiratory distress syndrome, peripheral neuropathies, DIC-like coagulopathies, hemorrhagic manifestations, rhabdomyolysis, pancreatitis and acute renal failure[<xref rid="B26" ref-type="bibr">26</xref>]. The diagnosis can be confirmed by microscopic identification of morulae in neutrophils on peripheral blood smear or in buffy coat, PCR or serology[<xref rid="B27" ref-type="bibr">27</xref>]. Based on the few case reports of anaplasmosis in recipients of kidney, pancreas or liver[<xref rid="B28" ref-type="bibr">28</xref>-<xref rid="B32" ref-type="bibr">32</xref>] the incidence of anaplasmosis in transplant recipients does not appear to be high and manifestations of the disease seem to be similar to non-transplant patients. In transplant patients, the clinical presentation commonly involved non-specific systemic symptoms. However, there was also a rather unusual presentation in a kidney recipient in the form of orchitis[<xref rid="B33" ref-type="bibr">33</xref>]. It was observed that immunosuppressive therapy does not seem to alter acute or convalescent antibody titers[<xref rid="B34" ref-type="bibr">34</xref>]. Solid organ transplant (SOT) recipients with anaplasmosis usually also have a good initial response to treatment with doxycycline[<xref rid="B33" ref-type="bibr">33</xref>].</p></sec><sec><title>Ehrlichia spp. (Human monocytic ehrlichiosis)</title><p>Human monocytic ehrlichiosis (HME) is a tick-borne zoonosis caused by <italic>Ehrlichia chaffeensis</italic> and less commonly, <italic>E. ewingii</italic>. HME occurs across the south-central, south-eastern, and mid-Atlantic states, corresponding to areas where their reservoirs (white-tailed deer) and vectors (<italic>Amblyomma americanum</italic> ticks) both exist[<xref rid="B35" ref-type="bibr">35</xref>]. The clinical manifestations of HME vary from a self-limited febrile illness to fatal multi-organ failure[<xref rid="B25" ref-type="bibr">25</xref>]. Severe manifestations such as acute respiratory distress syndrome, pulmonary hemorrhages, meningoencephalitis, toxic shock-like, and septic shock-like syndromes have also been described[<xref rid="B25" ref-type="bibr">25</xref>,<xref rid="B36" ref-type="bibr">36</xref>,<xref rid="B37" ref-type="bibr">37</xref>]. The diagnosis can be confirmed by PCR or serology[<xref rid="B25" ref-type="bibr">25</xref>,<xref rid="B38" ref-type="bibr">38</xref>]. In some cases, morulae may be observed in leukocytes on Wright stained peripheral blood smear, particularly in immunocompromised hosts[<xref rid="B25" ref-type="bibr">25</xref>,<xref rid="B39" ref-type="bibr">39</xref>]. There have been reports of HME transmission through SOT[<xref rid="B37" ref-type="bibr">37</xref>], as well as through blood product transfusions[<xref rid="B25" ref-type="bibr">25</xref>]. Ehrlichiosis was described in kidney[<xref rid="B37" ref-type="bibr">37</xref>,<xref rid="B40" ref-type="bibr">40</xref>-<xref rid="B44" ref-type="bibr">44</xref>], liver[<xref rid="B36" ref-type="bibr">36</xref>,<xref rid="B43" ref-type="bibr">43</xref>,<xref rid="B45" ref-type="bibr">45</xref>], lung[<xref rid="B38" ref-type="bibr">38</xref>,<xref rid="B42" ref-type="bibr">42</xref>,<xref rid="B43" ref-type="bibr">43</xref>,<xref rid="B46" ref-type="bibr">46</xref>] and heart transplant recipients[<xref rid="B42" ref-type="bibr">42</xref>,<xref rid="B43" ref-type="bibr">43</xref>]. Immunocompromised persons, particularly SOT recipients, more frequently develop severe and prolonged manifestations of ehrlichiosis with higher case-fatality rates[<xref rid="B25" ref-type="bibr">25</xref>,<xref rid="B37" ref-type="bibr">37</xref>,<xref rid="B42" ref-type="bibr">42</xref>]. Furthermore, SOT recipients showed having a higher risk to develop acute lung injury and acute respiratory distress syndrome[<xref rid="B42" ref-type="bibr">42</xref>]. However, one report showed that 15 transplant patients with ehrlichiosis had similar and favorable outcomes compared with immunocompetent patients[<xref rid="B43" ref-type="bibr">43</xref>]. Among SOT recipients, infected lung recipients showed more severe and progressive clinical course[<xref rid="B42" ref-type="bibr">42</xref>]. Some reports, have also described re-infections in liver transplant recipients, suggesting that initial infection may not provide long-lasting immunity in patients on immunosuppressive therapy[<xref rid="B45" ref-type="bibr">45</xref>].</p></sec><sec><title>Rickettsia spp.</title><p>Rickettsioses are bacterial infectious diseases that occur in endemic areas across the world. They are classified into two main groups: The spotted fever group with the main representatives; <italic>Rickettsia rickettsii</italic> (Rocky Mountain spotted fever; RMSF) transmitted by the ticks in the USA, Mexico and South America[<xref rid="B47" ref-type="bibr">47</xref>]; <italic>R. conorii</italic> (Mediterranean spotted fever; MSF) transmitted by dog ticks in Southern and Eastern Europe, Africa, India, Russia[<xref rid="B47" ref-type="bibr">47</xref>,<xref rid="B48" ref-type="bibr">48</xref>] and the typhus group which includes <italic>R. prowazekii</italic> (epidemic typhus) and <italic>R. typhi</italic> (murine typhus<sup>)[48]</sup>. Following a tick exposure, clinically significant rickettsial infections present with flu-like symptoms with or without eschar at the site of the tick bite, accompanied by rash. The clinical course is highly variable and ranges from self-limited to vasculitis-mediated organ failure and death[<xref rid="B49" ref-type="bibr">49</xref>]. The diagnosis of rickettsioses is most often established by serology. Indirect immunofluorescence assay (IFA) has been considered the gold standard. The test has limited utility in species determination within a serogroup due to extensive cross-reactivity and as any immunoglobulin-based assay in the context immunocom-promised patient should be interpreted with caution[<xref rid="B49" ref-type="bibr">49</xref>]. Rickettsioses have been rarely reported in the transplant population. The scarcity of the data implies that even in immunocompromised hosts majority of the infections are mild and rarely result in a malignant vasculitis-associated form. A case of RMSF in a cardiac transplant recipient from southern Utah demonstrated a prompt clinical response after empirical treatment with doxycycline and delayed development of rickettsia antibodies (5 mo after the infection)[<xref rid="B50" ref-type="bibr">50</xref>]. Only one case demonstrated the development of complications. Severe MSF infection has been reported in a kidney transplant recipient from Southern France, who developed flu-like symptoms, maculopapular rash and splenic rupture requiring splenectomy. Doxycycline therapy resulted in rapid improvement and favorable outcome[<xref rid="B51" ref-type="bibr">51</xref>]. Rickettsial infections are probably underrecognized and underreported in the transplant population.</p></sec><sec><title>Orientia tsutsugamushi (Scrub typhus)</title><p>Scrub typhus is a zoonosis caused by <italic>Orientia tsutsugamushi</italic>, an obligate intracellular bacterium. It is a common re-emerging rickettsial infection in India and many other countries in Southeast Asia, the Pacific Islands, and Northern Australia (the "tsutsugamushi triangle")[<xref rid="B52" ref-type="bibr">52</xref>]. <italic>Orientia tsutsugamushi</italic> is transmitted to humans by the bites of the larval life stage of infected <italic>Leptotrombidium</italic> mites (<italic>Leptotrombidium deliense</italic> and <italic>Leptotrombidium akamushi</italic>) while field rodents serve as reservoirs. The clinical presentation of scrub typhus ranges from nonspecific febrile illness to potentially fatal multi-organ involvement such as liver, kidney, or lung[<xref rid="B53" ref-type="bibr">53</xref>]. In some patients, an eschar may develop at the site of mite feeding. CNS involvement (meningitis, encephalitis) has also been observed[<xref rid="B54" ref-type="bibr">54</xref>]. The diagnosis of scrub typhus is usually made by a single IFA titer against <italic>O. tsutsugamushi</italic> of 400, a seroconversion or a 4-fold increase in IgG titer using paired serum samples[<xref rid="B55" ref-type="bibr">55</xref>]. So far, only one study described scrub typhus in a renal transplant recipient in India. The patient presented with fever, headache, meningeal signs, graft dysfunction, and eschar and responded well to intravenous azithromycin and became afebrile within 24 h[<xref rid="B53" ref-type="bibr">53</xref>]. Since many cases of scrub typhus are underdiagnosed, clinicians should consider in differential diagnosis this potentially fatal zoonosis in regions of endemicity.</p></sec><sec><title>Rift Valley fever virus</title><p>Rift Valley fever virus (RVFV) is a mosquito-borne phlebovirus. RVFV outbreaks in humans have been reported in Africa, the Indian Ocean islands, and the Arabian Peninsula[<xref rid="B56" ref-type="bibr">56</xref>]. Cattle, sheep, goats, and camels are particularly susceptible to RVF and serve as amplifying hosts for the virus[<xref rid="B57" ref-type="bibr">57</xref>]. RVFV transmission to humans occurs by direct contact with infected animals or their body fluids, consumption of raw milk or meat or by mosquito bites (<italic>Culex, Aedes</italic>)[<xref rid="B58" ref-type="bibr">58</xref>]. Human infections are usually subclinical or presenting as moderate to severe febrile illness while 1-2% of RVFV infections result in fatal haemorrhagic fever[<xref rid="B59" ref-type="bibr">59</xref>]. RVFV can be diagnosed by RNA detection, antigen detection or serology[<xref rid="B60" ref-type="bibr">60</xref>]. In 2015, an imported case of RVF in a kidney transplant recipient was reported in France. The initial clinical presentation was characteristic for acute hepatitis and four weeks later, the patient presented with a meningoencephalitis. IgM and IgG antibodies were detected in CSF and blood up to 2 mo after symptoms onset, whereas in urine and semen, RVFV RNA was detected by RT-PCR up to three and four mo, respectively. The severity of clinical presentation may have been related to immunosuppression, which might also have slowed down the clearance of the virus[<xref rid="B61" ref-type="bibr">61</xref>].</p></sec><sec><title>St. Louis encephalitis virus</title><p>St. Louis encephalitis virus (SLEV) is a mosquito-borne flavivirus. The virus can be found in the Western Hemisphere, but epidemics typically occur in the Ohio River-Mississippi River basin. Humans are dead-end hosts of a mosquito&#x02013;bird&#x02013;mosquito cycle[<xref rid="B62" ref-type="bibr">62</xref>]. While mostly asymptomatic, less than 1% of all SLEV infections lead to symptomatic disease ranging from febrile illness to aseptic meningitis or encephalitis[<xref rid="B63" ref-type="bibr">63</xref>]. Diagnosis is based on serology[<xref rid="B64" ref-type="bibr">64</xref>]. The prevalence of SLEV infections in transplant recipients is largely unknown. During the 2015 outbreak, three SOT recipients were hospitalized with confirmed neuroinvasive SLEV infection (meningoencephalitis) in Phoenix, Arizona. One patient died, whereas two other patients survived but required prolonged hospitalization. One patient recovered fully; the other patient had residual dysarthria[<xref rid="B65" ref-type="bibr">65</xref>].</p></sec><sec><title>ZIKV</title><p>ZIKV is an emerging mosquito-borne flavivirus. Before the large outbreak of ZIKV infection on Yap Island (Federated States of Micronesia), only sporadic cases were reported in Africa and Asia, but in 2007 ZIKV emerged as an important human pathogen[<xref rid="B66" ref-type="bibr">66</xref>,<xref rid="B67" ref-type="bibr">67</xref>]. Human infections mainly occur through the bite of <italic>Aedes</italic> mosquitoes (<italic>Ae. aegypti</italic> and <italic>Ae. albopictus)</italic>, however, non-vector borne transmission of ZIKV such as sexual and transplacental transmission was also reported[<xref rid="B68" ref-type="bibr">68</xref>]. Although symptoms associated with ZIKV infection are generally mild and the majority of infected persons do not develop any symptoms, ZIKV is also associated with severe neurological disorders, mainly Guillain-Barr&#x000e9; syndrome. Diagnostic testing for ZIKV infection can be accomplished using molecular and serologic methods[<xref rid="B69" ref-type="bibr">69</xref>,<xref rid="B70" ref-type="bibr">70</xref>]. Case reports describing ZIKV infection in transplant patients are limited. In 2015 and 2016, ZIKV infection was confirmed among 129 kidney transplants and 58 liver transplants tested in Brazil. All ZIKV-infected SOT recipients presented with complications, notably bacterial infections, and required hospitalization. Based on this small case series, it was not possible to assess the potential impact of ZIKV in the immunosuppressed SOT recipients, including infectious complications and graft rejection[<xref rid="B71" ref-type="bibr">71</xref>]. Therefore, further studies are needed to evaluate the impact of ZIKV infection in this population group.</p></sec><sec><title>Chikungunya virus</title><p>Chikungunya virus (CHIKV) is an emerging mosquito-borne alphavirus. Since 2004, CHIKV caused several large outbreaks in Africa, the Indian Ocean islands, Asia, Europe, and the Americas[<xref rid="B72" ref-type="bibr">72</xref>]. In an urban transmission cycle, humans are the major hosts and mosquitoes of the genus <italic>Aedes</italic> are vectors[<xref rid="B73" ref-type="bibr">73</xref>]. Although chikungunya fever is usually benign, prolonged polyarthralgia may lead to considerable disability in a significant proportion of patients[<xref rid="B72" ref-type="bibr">72</xref>]. Atypical manifestations include meningoen-cephalitis, myocarditis, respiratory, renal and hepatic failure[<xref rid="B74" ref-type="bibr">74</xref>,<xref rid="B75" ref-type="bibr">75</xref>]. Laboratory diagnosis is accomplished by detection of CHIKV RNA and/or detection of IgM and IgG antibodies[<xref rid="B72" ref-type="bibr">72</xref>]. Few data exist regarding the clinical characteristics of CHIKV infections in the transplant population[<xref rid="B76" ref-type="bibr">76</xref>-<xref rid="B79" ref-type="bibr">79</xref>]. In one case series of SOT recipients from Colombia with confirmed CHIKV infection, most patients had a benign clinical course with no severe complications[<xref rid="B78" ref-type="bibr">78</xref>]. A study from Brazil analyzed clinical symptoms of chikungunya in four kidney transplant recipients. The clinical picture was typical, none of patients developed any severe manifestations and all recovered fully with no complications[<xref rid="B77" ref-type="bibr">77</xref>]. Another Brazilian study showed similar results. SOT recipients with CHIKV infection seem to have a clinical presentation and course similar to those seen in the general population, with no apparent damage to the graft. Among liver transplant recipients, elevation of liver enzymes was not observed, and there was no clinical impact on graft function. Among kidney transplant recipients, only a few had a slight increase of serum creatinine levels, without acute kidney failure or dialytic support[<xref rid="B80" ref-type="bibr">80</xref>]. Although reports on the chikungunya in the transplant population are rare, the transplant community must be reminded that the risk of CHIKV infection should be considered in deceased organ donor candidates recently returned from travel to endemic areas[<xref rid="B76" ref-type="bibr">76</xref>].</p></sec><sec><title>Dengue virus</title><p>Dengue virus (DENV) is a mosquito-borne flavivirus widely distributed in the tropics and subtropics. In an urban cycle, the virus is transmitted from human to human by the bite of <italic>Ae. aegypti</italic> and <italic>Ae. albopictus</italic> mosquitoes. Non-vectorial DENV transmission through SOT can also occur[<xref rid="B81" ref-type="bibr">81</xref>]. The clinical presentations of DENV infection range from asymptomatic to severe illness with fatal outcome. The symptomatic cases are categorized as undifferentiated febrile illness, dengue fever, dengue hemorrhagic fever and dengue shock syndrome[<xref rid="B82" ref-type="bibr">82</xref>]. Etiologic diagnosis can be obtained by virus isolation, detection of NS1 antigen, DENV RNA or specific IgM and IgG antibodies[<xref rid="B83" ref-type="bibr">83</xref>]. SOT recipients showed a spectrum of clinical manifestations similar to the non-transplant population. However, the course of the illness can be prolonged with complications such as graft dysfunction. Fatal cases were also reported[<xref rid="B84" ref-type="bibr">84</xref>-<xref rid="B86" ref-type="bibr">86</xref>]. A Thai study analyzed outcomes of DENV infection in a large cohort of kidney transplant recipients. Although a transient decline in allograft function occurs in some patients, the overall clinical and allograft outcomes seemed to be favorable[<xref rid="B87" ref-type="bibr">87</xref>]. A Colombian study on retrospective case series of SOT recipients with DENV infection showed that regarding the clinical course, 75% of patients had at least one warning sign, 45% were managed in the intensive care unit, and 30% had severe dengue. However, all patients had a full recovery after the infection[<xref rid="B88" ref-type="bibr">88</xref>]. In contrast, a study from India showed that early post-transplant DENV infection appears to be severe and associated with more complications in kidney transplant recipients[<xref rid="B89" ref-type="bibr">89</xref>]. There have been limited descriptions of possible DENV transmission through SOT, of which the majority are classified as possible transmission due to the lack of DENV RNA confirmation in the donor[<xref rid="B81" ref-type="bibr">81</xref>,<xref rid="B90" ref-type="bibr">90</xref>,<xref rid="B91" ref-type="bibr">91</xref>]. A case of DENV transmission from donor to the recipient after liver transplantation was described in India. The recipient developed dengue fever without showing any features of severe graft dysfunction and recovered fully[<xref rid="B81" ref-type="bibr">81</xref>]. Several studies in SOT recipients who developed dengue through organ transplantation showed that the liver was the main target organ in all patients, even in subjects that received heart and kidney transplantation. Transplant patients were more likely to present with elevated liver transaminases and hyperbilirubinemia, suggesting that the liver could be more susceptible to DENV or is generally more compromised in transplant recipients[<xref rid="B81" ref-type="bibr">81</xref>,<xref rid="B91" ref-type="bibr">91</xref>,<xref rid="B92" ref-type="bibr">92</xref>]. A recently published study from India presented the first report on the detection of DENV in the donor cornea indicating the risk of iatrogenic DENV transmission through corneal transplantation[<xref rid="B93" ref-type="bibr">93</xref>]. To avoid DENV transmission by organ or tissue transplantation, the donors should be screened in endemic areas.</p></sec><sec><title>WNV</title><p>WNV is one of the most widely distributed emerging mosquito-borne flaviviruses. In a natural cycle, the virus is maintained in a bird-mosquito-bird cycle. Transmission to humans occurs through the bite of <italic>Culex</italic> mosquitoes[<xref rid="B94" ref-type="bibr">94</xref>]. Approximately 80% of immunocompetent individuals infected with WNV remain asymptomatic while 20% develop mild febrile disease (WNV fever). Less than 1% of infected individuals, mainly immunocompromised and elderly develop neuroinvasive disease (meningitis, encephalitis, myelitis)[<xref rid="B95" ref-type="bibr">95</xref>]. Diagnosis is confirmed by the detection of WNV IgM and IgG antibodies in serum/CSF with confirmation by virus neutralization test in samples with cross-reactive antibodies[<xref rid="B96" ref-type="bibr">96</xref>]. Since WNV IgM antibodies may persist up to 500 d in some patients, IgG avidity differentiates current/recent WNV infection from persistent IgM seropositivity from the previous WNV transmission season[<xref rid="B97" ref-type="bibr">97</xref>]. WNV RNA can be detected in blood, CSF and urine samples using RT-PCR, but molecular methods are less sensitive than serology[<xref rid="B98" ref-type="bibr">98</xref>]. WNV has been identified as a cause of both donor-derived and post-transplant infection[<xref rid="B99" ref-type="bibr">99</xref>]. WNV transmission by organ transplantation was first reported in 2002[<xref rid="B100" ref-type="bibr">100</xref>]. Thereafter, there are many reports on donor-derived or naturally acquired WNV infection in the adult transplant population[<xref rid="B101" ref-type="bibr">101</xref>-<xref rid="B108" ref-type="bibr">108</xref>]. Although WNV infection is associated with higher mortality in the transplant patients[<xref rid="B105" ref-type="bibr">105</xref>,<xref rid="B108" ref-type="bibr">108</xref>,<xref rid="B109" ref-type="bibr">109</xref>] there are some reports on WNV in SOT recipients with a complete recovery as well as asymptomatic infections[<xref rid="B108" ref-type="bibr">108</xref>,<xref rid="B110" ref-type="bibr">110</xref>]. Few reports describing post-transplant WNV neuroinvasive disease in pediatric patients showed a complete recovery in all patients[<xref rid="B104" ref-type="bibr">104</xref>,<xref rid="B111" ref-type="bibr">111</xref>,<xref rid="B112" ref-type="bibr">112</xref>]. In the light of the WNV (re-) emergence, clinicians should be aware that SOT recipients could be exposed to WNV <italic>via</italic> multiple sources. Therefore, WNV should be included in the differential diagnosis in all patients presenting with fever and neurological symptoms after transplantation during the arbovirus transmission season.</p></sec><sec><title>Usutu virus</title><p>Usutu virus (USUV) is a mosquito-borne flavivirus that emerged in Europe in 1996[<xref rid="B113" ref-type="bibr">113</xref>]. The natural cycle, geographic distribution and clinical symptoms of USUV overlap with WNV. Although human clinical cases of USUV infection are rarely reported, several recently published reports highlight its role in the etiology of neuroinvasive diseases[<xref rid="B114" ref-type="bibr">114</xref>-<xref rid="B117" ref-type="bibr">117</xref>]. Like WNV, the majority of USUV infections are asymptomatic or present as a non-specific febrile disease (USUV fever)[<xref rid="B117" ref-type="bibr">117</xref>]. Neuroinvasive disease was reported in both immunocompetent and immunocompromised patients in Italy, Croatia, and Hungary[<xref rid="B114" ref-type="bibr">114</xref>,<xref rid="B116" ref-type="bibr">116</xref>,<xref rid="B118" ref-type="bibr">118</xref>,<xref rid="B119" ref-type="bibr">119</xref>]. In addition, some atypical presentations such as facial paresis have also described[<xref rid="B120" ref-type="bibr">120</xref>]. However, there is only one published report on USUV infection in a transplanted patient in Italy. The patient who underwent an orthotopic liver transplant developed neuroinvasive disease in the post-transplant period[<xref rid="B121" ref-type="bibr">121</xref>]. Since many of USUV cases remain underdiagnosed or misdiagnosed as WNV due to similar clinical symptoms and serological cross-reactivity, clinicians should keep in mind this viral zoonosis, especially during the arbovirus transmission season.</p></sec><sec><title>Eastern equine encephalitis virus</title><p>Eastern equine encephalitis virus (EEEV) is a mosquito-borne alphavirus endemic to eastern North America. In nature, the virus spreads between <italic>Culiseta melanura</italic> mosquitoes found in forested wetlands. Mosquitoes of <italic>Aedes</italic> and <italic>Culex</italic> genera may transmit EEEV to humans[<xref rid="B122" ref-type="bibr">122</xref>]. Most persons infected with EEEV are asymptomatic or they present with a non-specific febrile illness, while less than &#x0003c; 5% develop neuroinvasive disease (meningitis, encephalitis). The case fatality rate is around 50% and many survivors suffer residual neurological sequelae[<xref rid="B123" ref-type="bibr">123</xref>]. There is only one report of organ-derived EEEV. In autumn 2017, three SOT recipients (lung, heart, liver) from a common donor developed encephalitis one week after transplantation. Lung and liver recipients died, while the heart recipient survived but had residual tremor. The donor and all organ recipients showed laboratory evidence of EEEV. The fact that all SOT recipients developed encephalitis suggests that the risk of neuroinvasive disease may be increased with this route of transmission. EEEV should be considered in SOT recipients who develop encephalitis after transplantation, particularly if donors and recipients reside in endemic areas of the USA[<xref rid="B124" ref-type="bibr">124</xref>].</p></sec><sec><title>Leishmania spp.</title><p>Leishmaniasis is a cosmopolitan zoonosis caused by the protozoan parasite of the genus <italic>Leishmania</italic>. It is transmitted by the bite of phlebotomine sandflies of the genus</p><p><italic>Phlebotomus</italic> (in the Old World) or <italic>Lutzomyia</italic> (in the New World). So far, at least 20 different <italic>Leishmania</italic> species have been associated with human infection. Clinical presentation of leishmaniasis includes cutaneous (CL), mucocutaneous (MCL), or visceral leishmaniasis (VL)[<xref rid="B125" ref-type="bibr">125</xref>]. CL occur in three different forms: Localized, diffuse and disseminated. CL is characterized by single or multiple skin ulcers, satellite lesions, or nodular lymphangitis. MCL present with mucosal tissue metastasis in the mouth and upper respiratory tract <italic>via</italic> lymphatic or hematogenous dissemination. VL is the most severe form of leishmaniasis and if untreated it is fatal in 95% of patients[<xref rid="B125" ref-type="bibr">125</xref>,<xref rid="B126" ref-type="bibr">126</xref>]. VL is usually caused by <italic>Leishmania donovani</italic> or <italic>L. infantum</italic> although other <italic>Leishmania</italic> species that usually cause CL have been described causing VL too[<xref rid="B125" ref-type="bibr">125</xref>]. Clinical presentation of VL is nonspecific with prolonged fever, anorexia, weight loss and overall poor health status. Typically the patients have hepatosplenomegaly and lymphadenopathy and in laboratory examination pancytopenia is frequently found[<xref rid="B127" ref-type="bibr">127</xref>]. The worldwide number of VL cases in SOT recipients has steadily increased since the 1990s, although VL is still a rare disease among transplant recipients[<xref rid="B128" ref-type="bibr">128</xref>]. VL is the most frequently observed clinical presentation in this population, followed by MCL and more rarely CL. Fever is the most common symptom of VL in SOT recipients, whereas organomegaly may be less frequent in SOT recipients than in immunocompetent individuals. Immunosuppression seems to predispose to development of MCL caused by viscerotropic strains[<xref rid="B128" ref-type="bibr">128</xref>-<xref rid="B130" ref-type="bibr">130</xref>]. Clinical presentation in these patients is almost the same as in immunocompetent persons although sometimes it can be atypical making it much more difficult for the diagnosis, therefore it is frequently overlooked or delayed in transplant patients. The combination of conventional and molecular diagnostic methods may serve as the best approach[<xref rid="B130" ref-type="bibr">130</xref>].</p></sec></sec><sec><title>NON-VECTOR-BORNE ZOONOSES</title><sec><title>Hepatitis E virus</title><p>HEV is a non-enveloped RNA virus that belongs to the family <italic>Hepeviridae</italic>. Genotypes 1 and 2 are restricted to humans only, while 3 to 8 are zoonotic genotypes. In fragile sanitary infrastructure (<italic>e.g.</italic> Asia, Africa, Mexico) genotypes 1 and 2 usually cause human diseases, whereas genotypes 3 and 4 are nowadays found to be the most common genotypes in high-income countries[<xref rid="B131" ref-type="bibr">131</xref>]. Waterborne, zoonotic and foodborne transmissions are the most common routes of infection, with the primary reservoirs (Europe) being domestic pigs, wild boars, and deer[<xref rid="B131" ref-type="bibr">131</xref>]. Parenteral transmission, transmission <italic>via</italic> solid organs and blood components has been increasingly recognized[<xref rid="B131" ref-type="bibr">131</xref>,<xref rid="B132" ref-type="bibr">132</xref>]. HEV is diagnosed through serology and nucleic acid amplification test, although, only HEV RNA testing is recommended for the immunocompromised population[<xref rid="B131" ref-type="bibr">131</xref>]. Hepatitis E virus infection typically manifests as an acute self-limiting hepatitis, but may also present as fulminant hepatitis (pregnant women) or acute-on&#x02013;chronic liver failure in patients with pre-existing liver diseases or extra-hepatic manifestations[<xref rid="B131" ref-type="bibr">131</xref>,<xref rid="B132" ref-type="bibr">132</xref>]. After solid-organ transplantation, genotype 3 and 4 HEV can be responsible for chronic hepatitis (positive HEV RNA &#x0003e; 6 mo) where the majority of cases are asymptomatic accompanied by mild liver test abnormalities. Chronic infections may rapidly progress to liver fibrosis and cirrhosis[<xref rid="B133" ref-type="bibr">133</xref>]. Thus far, there have been numerous reports of chronic hepatitis E in the liver, kidney, heart, lungs, liver-kidney, kidney-pancreas, islet cell recipients[<xref rid="B133" ref-type="bibr">133</xref>,<xref rid="B134" ref-type="bibr">134</xref>]. Furthermore, extrahepatic manifestations are also common in SOT recipients, including neurological (neuralgic amyotrophy, Guillain-Barr&#x000e9; syndrome, encephalitis, myelitis)[<xref rid="B135" ref-type="bibr">135</xref>], renal manifestations (membranoproliferative and membranous glomerulonephritis)[<xref rid="B136" ref-type="bibr">136</xref>], as well as thrombocytopenia[<xref rid="B135" ref-type="bibr">135</xref>] and cryoglobulinemia[<xref rid="B136" ref-type="bibr">136</xref>]. After an acute infection, one third of the patients will clear the virus after the reduction of immunosuppression[<xref rid="B131" ref-type="bibr">131</xref>]. In other patients (about 60%), the infection will typically progress to chronic forms and lead to the need for additional treatments[<xref rid="B131" ref-type="bibr">131</xref>,<xref rid="B133" ref-type="bibr">133</xref>]. A recent multi-center study which included 255 solid organ transplant recipients, confirmed that ribavirin is highly efficient for treating chronic HEV infection and that HEV RNA polymerase mutations do not play a role in HEV clearance[<xref rid="B137" ref-type="bibr">137</xref>].</p></sec><sec><title>Rabies virus</title><p>Rabies virus (RABV) is a neurotropic lyssavirus that belongs to the family <italic>Rhabdoviridae</italic>. With some exceptions (particularly islands), the RABV is found worldwide, however almost all human deaths caused by RABV occur in Asia and Africa. Typical reservoirs of RABV are domestic dog (Africa and Asia), jackal (Africa), mongoose (Africa), fox (Europe, Asia, America), raccoon (America), skunk, coyote (America) and bats (Europe, Australia, America). Humans become infected by the bite of infected animals or by contact with infectious saliva through mucous membranes or breaks in the skin[<xref rid="B138" ref-type="bibr">138</xref>]. Human-to-human RABV transmission may occur through tissue or organ transplantation. The first case of RABV transmitted through corneal transplantation was reported in 1978 in the USA[<xref rid="B139" ref-type="bibr">139</xref>], followed by several other reports[<xref rid="B140" ref-type="bibr">140</xref>-<xref rid="B142" ref-type="bibr">142</xref>]. However, rabies transmission through SOT transplantation has rarely been reported. In 2004 (USA), four recipients of a liver, kidneys and an arterial segment from a common organ donor with unrecognized rabies developed encephalitis within 30 d after transplantation. The patients presented with fever and altered mental status (confusion, agitation, tremors, and delirium). All patients died within 50 d after transplantation[<xref rid="B143" ref-type="bibr">143</xref>]. In 2013, a patient died of rabies 18 mo after receiving a deceased-donor kidney transplant in the USA. Three other recipients (kidney, heart, and liver) did not show symptoms consistent with rabies or encephalitis. All received post-exposure prophylaxis with rabies immune globulin and vaccine and remain asymptomatic[<xref rid="B144" ref-type="bibr">144</xref>]. The transmission of RABV through SOT has become a notable problem in China. In 2015, two patients who received kidney transplants from the same donor presented with typical symptoms of rabies and eventually died. In 2016, infected donor organs were transplanted to three patients. Two recipients that were diagnosed with rabies died[<xref rid="B145" ref-type="bibr">145</xref>]. In 2016, another two cases of RABV transmission through SOT were reported in China. Two kidney transplant recipients died, whereas a liver recipient did not show any signs or symptoms of rabies or encephalitis[<xref rid="B146" ref-type="bibr">146</xref>]. A case of RABV transmission through a kidney transplant was also reported in a child in Kuwait[<xref rid="B147" ref-type="bibr">147</xref>]. Since the mortality rate of rabies is extremely high, rabies should be considered in patients with acute progressive encephalitis of unexplained etiology, especially for potential organ donors[<xref rid="B144" ref-type="bibr">144</xref>].</p></sec><sec><title>Lymphocytic choriomeningitis virus</title><p>Lymphocytic choriomeningitis virus (LCMV) is an Old World arenavirus distributed in Europe and Americas. The main reservoir of LCMV is a house mouse (<italic>Mus musculus, Mus domesticus</italic>), but some other rodents including pet animals may also transmit the virus[<xref rid="B148" ref-type="bibr">148</xref>]. LCMV transmission to humans occurs by inhalation of aerosolized excreta/secreta of infected rodents (urine and saliva), bites and contact with rodent blood[<xref rid="B149" ref-type="bibr">149</xref>]. LCMV infection in immunocompetent individuals is typically asymptomatic or it presents as nonspecific febrile illness or aseptic meningitis[<xref rid="B99" ref-type="bibr">99</xref>]. In contrast, immunocompromised hosts such as transplant recipients develop severe infection with multisystem organ failure and high mortality rate. Several clusters of organ-transplant-associated LCMV infections have been reported in the USA from 2003 to 2013. Signs and symptoms suggestive of LCMV infection occurred in clusters of SOT recipients, in 2003 and 2005. Laboratory testing revealed the LCMV in all the recipients, however, the virus could not be detected in donors. Seven of eight recipients died, 9-76 d after transplantation. In the 2005 cluster, the donor reported contact with a hamster pet, infected with an LCMV strain identical to that detected in the organ recipients. No source of infection was found in the 2003 cluster[<xref rid="B150" ref-type="bibr">150</xref>]. In 2010-2011, four clusters of organ-transplant-associated LCMV transmissions have been reported; 11 of 14 recipients died[<xref rid="B151" ref-type="bibr">151</xref>]. The majority of patients with fatal donor-derived LCMV infection showed hepatitis as a prominent feature[<xref rid="B99" ref-type="bibr">99</xref>]. In a recently published study, a case of LCMV infection in a renal transplant recipient that was non-organ donor-derived was described. The patient presented with meningoencephalitis acquired by the exposure to mice excreta. The clinical course was complicated by the development of hydrocephalus, requiring a ventriculoperitoneal shunt[<xref rid="B152" ref-type="bibr">152</xref>]. Although the risk of LCMV among organ recipients is low, clinicians should be aware of the possibility of transplant-transmitted LCMV infection.</p></sec><sec><title>Toxoplasma gondii (Toxoplasmosis)</title><p>Toxoplasmosis is a zoonotic disease caused by a protozoan <italic>Toxoplasma gondii</italic>. It is an obligate intracellular parasite that is widely spread all over the world. Warm-blooded vertebrates are the intermediate hosts where asexual reproduction takes place. This results in the formation of tachyzoites and bradyzoites. Tachyzoites can invade various tissues <italic>e.g.</italic> lungs, CNS and heart but also, they can cause intrauterine infection with possible transplacental transmission to the fetus. Bradyzoites form the tissue cysts in the intermediate host. Felids are the only definite hosts where sexual reproduction occurs resulting in excretion of oocysts into the environment <italic>via</italic> feces. Transmission to humans occurs through the ingestion of water, vegetables, or soil contaminated with oocysts or raw or undercooked meat containing tissue cysts with bradyzoites[<xref rid="B153" ref-type="bibr">153</xref>]. The worldwide prevalence of toxoplasmosis in the human population varies from 10 to 80%[<xref rid="B154" ref-type="bibr">154</xref>,<xref rid="B155" ref-type="bibr">155</xref>]. The course of infection is generally benign and most infected individuals remain asymptomatic or mildly symptomatic. The disease may have an acute or chronic form. The presence of bradyzoites in tissue cysts represents the latent infection which can reactivate at any age. Prenatal transplacental infection can result in intrauterine fetal growth retardation, hepatosplenomegaly, eye and/or brain damage, fetal death or premature birth. If symptomatic, postnatal toxoplasmosis can present as fever with lymphadenopathy. Chorioretinitis as a manifestation of acquired toxoplasmosis is seen less frequently. Rarely, a potentially fatal disseminated disease, myocarditis, pneumonitis, hepatitis, myositis or encephalitis can be seen in an immunocompetent patients[<xref rid="B156" ref-type="bibr">156</xref>]. Toxoplasmosis as an infectious complication is a well-recognized entity in SOT recipients. If it presents in the first three post-transplant mo, the graft transmission is most likely, but if it presents after this early period, most often it is the result of the latent infection reactivation or the primary infection. Clinical presentation in SOT patients is more severe as cerebral, disseminated and pulmonary toxoplasmosis is seen more often than mild forms (fever and ocular toxoplasmosis). Even more severe forms with higher mortality are seen in graft transmission[<xref rid="B157" ref-type="bibr">157</xref>,<xref rid="B158" ref-type="bibr">158</xref>]. As toxoplasmosis in SOT patients might be a fatal disease and as at the same time it is a preventable infection, clinicians have to follow the screening and chemoprophylaxis guidelines to optimize the patient&#x02019;s outcome.</p></sec></sec><sec><title>CONCLUSION</title><p>This article summarizes the most important emerging and neglected zoonotic pathogens and their clinical presentations in the transplant population. In recent decades, human activities along with climatic changes have led to the shifts in environmental conditions influencing among others, the transmission and distribution of zoonotic pathogens. As the number of zoonotic diseases is increasing, the spreading trends are likely to continue in the future. In parallel, the expanding transplant population worldwide imposes additional challenges for diagnostics and treatment of zoonotic infections. Immunosuppressed state may influence the serologic response and delay diagnosis, modify and aggravate clinical presentation and prolong treatment and recovery. Keeping that in mind is of particular importance in the context of emerging and neglected pathogens which may not be familiar to the wider community of transplant professionals in different geographical locations. The increasing trend of the pathogens transmitted and shared between animals and humans in global and especially transplant population, emphasizes the need for the multidisciplinary approach (&#x0201c;One Health&#x0201d;) in the surveillance and control of zoonotic infections around the world.</p></sec><sec><title>ACKNOWLEDGEMENTS</title><p>This study was supported in part by the Croatian Science Foundation, project No. IP 2016-06-7456: Prevalence and molecular epidemiology of emerging and re-emerging neuroinvasive arboviral infections in Croatia; CRONEUROARBO (to TVC).</p></sec></body><back><fn-group><fn fn-type="COI-statement"><p>Conflict-of-interest statement: The authors have no conflicts of interest to declare.</p></fn><fn><p>Manuscript source: Invited manuscript</p></fn><fn><p>Peer-review started: December 22, 2019</p></fn><fn><p>First decision: February 20, 2020</p></fn><fn><p>Article in press: March 22, 2020</p></fn><fn><p>Specialty type: Transplantation</p></fn><fn><p>Country of origin: Croatia</p></fn><fn><p>Peer-review report classification</p></fn><fn><p>Grade A (Excellent): A</p></fn><fn><p>Grade B (Very good): B</p></fn><fn><p>Grade C (Good): 0</p></fn><fn><p>Grade D (Fair): 0</p></fn><fn><p>Grade E (Poor): 0</p></fn><fn><p>P-Reviewer: Hibberd AD, Maggi F S-Editor: Wang YQ L-Editor: A E-Editor: Qi LL</p></fn></fn-group><ref-list><ref id="B1"><label>1</label><element-citation publication-type="webpage"><collab>World Health Organization (WHO)</collab><article-title>Neglected zoonotic diseases</article-title><comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/neglected_diseases/diseases/zoonoses/en/">https://www.who.int/neglected_diseases/diseases/zoonoses/en/</ext-link></comment></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karesh</surname><given-names>WB</given-names></name><name><surname>Dobson</surname><given-names>A</given-names></name><name><surname>Lloyd-Smith</surname><given-names>JO</given-names></name><name><surname>Lubroth</surname><given-names>J</given-names></name><name><surname>Dixon</surname><given-names>MA</given-names></name><name><surname>Bennett</surname><given-names>M</given-names></name><name><surname>Aldrich</surname><given-names>S</given-names></name><name><surname>Harrington</surname><given-names>T</given-names></name><name><surname>Formenty</surname><given-names>P</given-names></name><name><surname>Loh</surname><given-names>EH</given-names></name><name><surname>Machalaba</surname><given-names>CC</given-names></name><name><surname>Thomas</surname><given-names>MJ</given-names></name><name><surname>Heymann</surname><given-names>DL</given-names></name></person-group><article-title>Ecology of zoonoses: natural and unnatural histories</article-title><source>Lancet</source><year>2012</year><volume>380</volume><fpage>1936</fpage><lpage>1945</lpage><pub-id pub-id-type="pmid">23200502</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>J&#x000e1;nov&#x000e1;</surname><given-names>E</given-names></name></person-group><article-title>Emerging and threatening vector-borne zoonoses in the world and in Europe: a brief update</article-title><source>Pathog Glob Health</source><year>2019</year><volume>113</volume><fpage>49</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">30916639</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Jorgensen</surname><given-names>JH</given-names></name><name><surname>Pfaller</surname><given-names>JA</given-names></name><name><surname>Carroll</surname><given-names>KC</given-names></name><name><surname>Landry</surname><given-names>ML</given-names></name><name><surname>Funke</surname><given-names>G</given-names></name><name><surname>Richter</surname><given-names>SS</given-names></name><name><surname>Warnock</surname><given-names>DW</given-names></name></person-group><article-title>Manual of Clinical Microbiology</article-title><comment>11th ed. Washington: ASM Press, 2017</comment></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vilibic-Cavlek</surname><given-names>T</given-names></name><name><surname>Savic</surname><given-names>V</given-names></name><name><surname>Petrovic</surname><given-names>T</given-names></name><name><surname>Toplak</surname><given-names>I</given-names></name><name><surname>Barbic</surname><given-names>L</given-names></name><name><surname>Petric</surname><given-names>D</given-names></name><name><surname>Tabain</surname><given-names>I</given-names></name><name><surname>Hrnjakovic-Cvjetkovic</surname><given-names>I</given-names></name><name><surname>Bogdanic</surname><given-names>M</given-names></name><name><surname>Klobucar</surname><given-names>A</given-names></name><name><surname>Mrzljak</surname><given-names>A</given-names></name><name><surname>Stevanovic</surname><given-names>V</given-names></name><name><surname>Dinjar-Kujundzic</surname><given-names>P</given-names></name><name><surname>Radmanic</surname><given-names>L</given-names></name><name><surname>Monaco</surname><given-names>F</given-names></name><name><surname>Listes</surname><given-names>E</given-names></name><name><surname>Savini</surname><given-names>G</given-names></name></person-group><article-title>Emerging Trends in the Epidemiology of West Nile and Usutu Virus Infections in Southern Europe</article-title><source>Front Vet Sci</source><year>2019</year><volume>6</volume><fpage>437</fpage><pub-id pub-id-type="pmid">31867347</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camp</surname><given-names>JV</given-names></name><name><surname>Nowotny</surname><given-names>N</given-names></name></person-group><article-title>The knowns and unknowns of West Nile virus in Europe: what did we learn from the 2018 outbreak?</article-title><source>Expert Rev Anti Infect Ther</source><year>2020</year><volume>18</volume><fpage>145</fpage><lpage>154</lpage><pub-id pub-id-type="pmid">31914833</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="webpage"><collab>European Centre for Disease Prevention and Control (ECDC)</collab><article-title>Historical Data by Year - West Nile Fever Seasonal Surveillance 2018</article-title><comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://ecdc.europa.eu/en/west-nile-fever/surveillance-and-disease-data/historical">https://ecdc.europa.eu/en/west-nile-fever/surveillance-and-disease-data/historical</ext-link></comment></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="book"><collab>Centers for Disease Control and Prevention (CDC)</collab><article-title>Zika virus. Statistics maps 2016</article-title><comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/zika/reporting/2016-case-counts.html">https://www.cdc.gov/zika/reporting/2016-case-counts.html</ext-link></comment></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><collab>The Lancet</collab><article-title>Growing concerns of hepatitis E in Europe</article-title><source>Lancet</source><year>2017</year><volume>390</volume><fpage>334</fpage></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><collab>European Association for the Study of the Liver</collab><article-title>EASL Clinical Practice Guidelines: Liver transplantation</article-title><source>J Hepatol</source><year>2016</year><volume>64</volume><fpage>433</fpage><lpage>485</lpage><pub-id pub-id-type="pmid">26597456</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bodzin</surname><given-names>AS</given-names></name><name><surname>Baker</surname><given-names>TB</given-names></name></person-group><article-title>Liver Transplantation Today: Where We Are Now and Where We Are Going</article-title><source>Liver Transpl</source><year>2018</year><volume>24</volume><fpage>1470</fpage><lpage>1475</lpage><pub-id pub-id-type="pmid">30080954</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mansfield</surname><given-names>KL</given-names></name><name><surname>Johnson</surname><given-names>N</given-names></name><name><surname>Phipps</surname><given-names>LP</given-names></name><name><surname>Stephenson</surname><given-names>JR</given-names></name><name><surname>Fooks</surname><given-names>AR</given-names></name><name><surname>Solomon</surname><given-names>T</given-names></name></person-group><article-title>Tick-borne encephalitis virus - a review of an emerging zoonosis</article-title><source>J Gen Virol</source><year>2009</year><volume>90</volume><fpage>1781</fpage><lpage>1794</lpage><pub-id pub-id-type="pmid">19420159</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerlik</surname><given-names>J</given-names></name><name><surname>Avdi&#x0010d;ov&#x000e1;</surname><given-names>M</given-names></name><name><surname>&#x00160;tefkovi&#x0010d;ov&#x000e1;</surname><given-names>M</given-names></name><name><surname>Tarkovsk&#x000e1;</surname><given-names>V</given-names></name><name><surname>P&#x000e1;ntikov&#x000e1; Valachov&#x000e1;</surname><given-names>M</given-names></name><name><surname>Mol&#x0010d;&#x000e1;nyi</surname><given-names>T</given-names></name><name><surname>Mezencev</surname><given-names>R</given-names></name></person-group><article-title>Slovakia reports highest occurrence of alimentary tick-borne encephalitis in Europe: Analysis of tick-borne encephalitis outbreaks in Slovakia during 2007-2016</article-title><source>Travel Med Infect Dis</source><year>2018</year><volume>26</volume><fpage>37</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">30012472</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruzek</surname><given-names>D</given-names></name><name><surname>Av&#x00161;i&#x0010d; &#x0017d;upanc</surname><given-names>T</given-names></name><name><surname>Borde</surname><given-names>J</given-names></name><name><surname>Chrdle</surname><given-names>A</given-names></name><name><surname>Eyer</surname><given-names>L</given-names></name><name><surname>Karganova</surname><given-names>G</given-names></name><name><surname>Kholodilov</surname><given-names>I</given-names></name><name><surname>Knap</surname><given-names>N</given-names></name><name><surname>Kozlovskaya</surname><given-names>L</given-names></name><name><surname>Matveev</surname><given-names>A</given-names></name><name><surname>Miller</surname><given-names>AD</given-names></name><name><surname>Osolodkin</surname><given-names>DI</given-names></name><name><surname>&#x000d6;verby</surname><given-names>AK</given-names></name><name><surname>Tikunova</surname><given-names>N</given-names></name><name><surname>Tkachev</surname><given-names>S</given-names></name><name><surname>Zajkowska</surname><given-names>J</given-names></name></person-group><article-title>Tick-borne encephalitis in Europe and Russia: Review of pathogenesis, clinical features, therapy, and vaccines</article-title><source>Antiviral Res</source><year>2019</year><volume>164</volume><fpage>23</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">30710567</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vilibic-Cavlek</surname><given-names>T</given-names></name><name><surname>Barbic</surname><given-names>L</given-names></name><name><surname>Stevanovic</surname><given-names>V</given-names></name><name><surname>Petrovic</surname><given-names>G</given-names></name><name><surname>Mlinaric-Galinovic</surname><given-names>G</given-names></name></person-group><article-title>IgG Avidity: an Important Serologic Marker for the Diagnosis of Tick-Borne Encephalitis Virus Infection</article-title><source>Pol J Microbiol</source><year>2016</year><volume>65</volume><fpage>119</fpage><lpage>121</lpage><pub-id pub-id-type="pmid">27282004</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipowski</surname><given-names>D</given-names></name><name><surname>Popiel</surname><given-names>M</given-names></name><name><surname>Perlejewski</surname><given-names>K</given-names></name><name><surname>Nakamura</surname><given-names>S</given-names></name><name><surname>Bukowska-Osko</surname><given-names>I</given-names></name><name><surname>Rzadkiewicz</surname><given-names>E</given-names></name><name><surname>Dzieciatkowski</surname><given-names>T</given-names></name><name><surname>Milecka</surname><given-names>A</given-names></name><name><surname>Wenski</surname><given-names>W</given-names></name><name><surname>Ciszek</surname><given-names>M</given-names></name><name><surname>Debska-Slizien</surname><given-names>A</given-names></name><name><surname>Ignacak</surname><given-names>E</given-names></name><name><surname>Cortes</surname><given-names>KC</given-names></name><name><surname>Pawelczyk</surname><given-names>A</given-names></name><name><surname>Horban</surname><given-names>A</given-names></name><name><surname>Radkowski</surname><given-names>M</given-names></name><name><surname>Laskus</surname><given-names>T</given-names></name></person-group><article-title>A Cluster of Fatal Tick-borne Encephalitis Virus Infection in Organ Transplant Setting</article-title><source>J Infect Dis</source><year>2017</year><volume>215</volume><fpage>896</fpage><lpage>901</lpage><pub-id pub-id-type="pmid">28453842</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radolf</surname><given-names>JD</given-names></name><name><surname>Caimano</surname><given-names>MJ</given-names></name><name><surname>Stevenson</surname><given-names>B</given-names></name><name><surname>Hu</surname><given-names>LT</given-names></name></person-group><article-title>Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes</article-title><source>Nat Rev Microbiol</source><year>2012</year><volume>10</volume><fpage>87</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">22230951</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGinley-Smith</surname><given-names>DE</given-names></name><name><surname>Tsao</surname><given-names>SS</given-names></name></person-group><article-title>Dermatoses from ticks</article-title><source>J Am Acad Dermatol</source><year>2003</year><volume>49</volume><fpage>363</fpage><lpage>92; quiz 393-6</lpage><pub-id pub-id-type="pmid">12963900</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krawczuk</surname><given-names>K</given-names></name><name><surname>Czupryna</surname><given-names>P</given-names></name><name><surname>Pancewicz</surname><given-names>S</given-names></name><name><surname>O&#x00142;dak</surname><given-names>E</given-names></name><name><surname>Kr&#x000f3;l</surname><given-names>M</given-names></name><name><surname>Moniuszko-Malinowska</surname><given-names>A</given-names></name></person-group><article-title>Neuroborreliosis &#x02013; clinical presentation &#x02013; Current state of knowledge</article-title><source>Przegl Epidemiol</source><year>2019</year><volume>73</volume><fpage>321</fpage><lpage>328</lpage><pub-id pub-id-type="pmid">31766829</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maraspin</surname><given-names>V</given-names></name><name><surname>Cimperman</surname><given-names>J</given-names></name><name><surname>Lotric-Furlan</surname><given-names>S</given-names></name><name><surname>Logar</surname><given-names>M</given-names></name><name><surname>Ruzi&#x00107;-Sablji&#x00107;</surname><given-names>E</given-names></name><name><surname>Strle</surname><given-names>F</given-names></name></person-group><article-title>Erythema migrans in solid-organ transplant recipients</article-title><source>Clin Infect Dis</source><year>2006</year><volume>42</volume><fpage>1751</fpage><lpage>1754</lpage><pub-id pub-id-type="pmid">16705583</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chochon</surname><given-names>F</given-names></name><name><surname>Kanfer</surname><given-names>A</given-names></name><name><surname>Rondeau</surname><given-names>E</given-names></name><name><surname>Sraer</surname><given-names>JD</given-names></name></person-group><article-title>Lyme disease in a kidney transplant recipient</article-title><source>Transplantation</source><year>1994</year><volume>57</volume><fpage>1687</fpage><lpage>1688</lpage></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryan</surname><given-names>MF</given-names></name><name><surname>Thorn</surname><given-names>C</given-names></name></person-group><article-title>Lyme carditis in an immunocompromised patient</article-title><source>Case Rep Emerg Med</source><year>2013</year><volume>2013</volume><fpage>380734</fpage><pub-id pub-id-type="pmid">24083037</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dumler</surname><given-names>JS</given-names></name><name><surname>Choi</surname><given-names>KS</given-names></name><name><surname>Garcia-Garcia</surname><given-names>JC</given-names></name><name><surname>Barat</surname><given-names>NS</given-names></name><name><surname>Scorpio</surname><given-names>DG</given-names></name><name><surname>Garyu</surname><given-names>JW</given-names></name><name><surname>Grab</surname><given-names>DJ</given-names></name><name><surname>Bakken</surname><given-names>JS</given-names></name></person-group><article-title>Human granulocytic anaplasmosis and Anaplasma phagocytophilum</article-title><source>Emerg Infect Dis</source><year>2005</year><volume>11</volume><fpage>1828</fpage><lpage>1834</lpage><pub-id pub-id-type="pmid">16485466</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><collab>European Centre for Disease Prevention and Control (ECDC)</collab><comment>Human granulocytic anaplasmosis. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.ecdc.europa.eu/en/human-granulocytic-anaplasmosis">https://www.ecdc.europa.eu/en/human-granulocytic-anaplasmosis</ext-link></comment></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><collab>Centers for Disease Control and Prevention (CDC)</collab><comment>Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and Anaplasmosis &#x02014; United States A Practical Guide for Health Care and Public Health Professionals. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/mmwr/volumes/65/rr/rr6502a1.htm">https://www.cdc.gov/mmwr/volumes/65/rr/rr6502a1.htm</ext-link></comment></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakken</surname><given-names>JS</given-names></name><name><surname>Dumler</surname><given-names>JS</given-names></name></person-group><article-title>Human granulocytic ehrlichiosis</article-title><source>Clin Infect Dis</source><year>2000</year><volume>31</volume><fpage>554</fpage><lpage>560</lpage><pub-id pub-id-type="pmid">10987720</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez</surname><given-names>E</given-names></name><name><surname>Vannier</surname><given-names>E</given-names></name><name><surname>Wormser</surname><given-names>GP</given-names></name><name><surname>Hu</surname><given-names>LT</given-names></name></person-group><article-title>Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: A Review</article-title><source>JAMA</source><year>2016</year><volume>315</volume><fpage>1767</fpage><lpage>1777</lpage><pub-id pub-id-type="pmid">27115378</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vannorsdall</surname><given-names>MD</given-names></name><name><surname>Thomas</surname><given-names>S</given-names></name><name><surname>Smith</surname><given-names>RP</given-names></name><name><surname>Zimmerman</surname><given-names>R</given-names></name><name><surname>Christman</surname><given-names>R</given-names></name><name><surname>Vella</surname><given-names>JP</given-names></name></person-group><article-title>Human granulocytic ehrlichiosis in a renal allograft recipient: review of the clinical spectrum of disease in solid organ transplant patients</article-title><source>Transpl Infect Dis</source><year>2002</year><volume>4</volume><fpage>97</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">12220247</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adachi</surname><given-names>JA</given-names></name><name><surname>Grimm</surname><given-names>EM</given-names></name><name><surname>Johnson</surname><given-names>P</given-names></name><name><surname>Uthman</surname><given-names>M</given-names></name><name><surname>Kaplan</surname><given-names>B</given-names></name><name><surname>Rakita</surname><given-names>RM</given-names></name></person-group><article-title>Human granulocytic ehrlichiosis in a renal transplant patient: case report and review of the literature</article-title><source>Transplantation</source><year>1997</year><volume>64</volume><fpage>1139</fpage><lpage>1142</lpage><pub-id pub-id-type="pmid">9355830</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antony</surname><given-names>SJ</given-names></name><name><surname>Dummer</surname><given-names>JS</given-names></name><name><surname>Hunter</surname><given-names>E</given-names></name></person-group><article-title>Human ehrlichiosis in a liver transplant recipient</article-title><source>Transplantation</source><year>1995</year><volume>60</volume><fpage>879</fpage><lpage>881</lpage><pub-id pub-id-type="pmid">7482752</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Assi</surname><given-names>MA</given-names></name><name><surname>Yao</surname><given-names>JD</given-names></name><name><surname>Walker</surname><given-names>RC</given-names></name></person-group><article-title>Lyme disease followed by human granulocytic anaplasmosis in a kidney transplant recipient</article-title><source>Transpl Infect Dis</source><year>2007</year><volume>9</volume><fpage>66</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">17313478</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trofe</surname><given-names>J</given-names></name><name><surname>Reddy</surname><given-names>KS</given-names></name><name><surname>Stratta</surname><given-names>RJ</given-names></name><name><surname>Flax</surname><given-names>SD</given-names></name><name><surname>Somerville</surname><given-names>KT</given-names></name><name><surname>Alloway</surname><given-names>RR</given-names></name><name><surname>Egidi</surname><given-names>MF</given-names></name><name><surname>Shokouh-Amiri</surname><given-names>MH</given-names></name><name><surname>Gaber</surname><given-names>AO</given-names></name></person-group><article-title>Human granulocytic ehrlichiosis in pancreas transplant recipients</article-title><source>Transpl Infect Dis</source><year>2001</year><volume>3</volume><fpage>34</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">11429038</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khatri</surname><given-names>A</given-names></name><name><surname>Lloji</surname><given-names>A</given-names></name><name><surname>Doobay</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Knoll</surname><given-names>B</given-names></name><name><surname>Dhand</surname><given-names>A</given-names></name><name><surname>Nog</surname><given-names>R</given-names></name></person-group><article-title>Anaplasma phagocytophilum presenting with orchitis in a renal transplant recipient</article-title><source>Transpl Infect Dis</source><year>2019</year><volume>21</volume><fpage>e13129</fpage><pub-id pub-id-type="pmid">31215144</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dana</surname><given-names>A</given-names></name><name><surname>Antony</surname><given-names>A</given-names></name><name><surname>Patel</surname><given-names>MJ</given-names></name></person-group><article-title>Vector-borne infections in solid organ transplant recipients</article-title><source>Int J Dermatol</source><year>2012</year><volume>51</volume><fpage>1</fpage><lpage>11</lpage></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dumler</surname><given-names>JS</given-names></name><name><surname>Madigan</surname><given-names>JE</given-names></name><name><surname>Pusterla</surname><given-names>N</given-names></name><name><surname>Bakken</surname><given-names>JS</given-names></name></person-group><article-title>Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment</article-title><source>Clin Infect Dis</source><year>2007</year><volume>45 Suppl 1</volume><fpage>S45</fpage><lpage>S51</lpage><pub-id pub-id-type="pmid">17582569</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>HP</given-names></name><name><surname>Dumler</surname><given-names>JS</given-names></name><name><surname>Maley</surname><given-names>WR</given-names></name><name><surname>Klein</surname><given-names>AS</given-names></name><name><surname>Burdick</surname><given-names>JF</given-names></name><name><surname>Fred Poordad</surname><given-names>F</given-names></name><name><surname>Thuluvath</surname><given-names>PJ</given-names></name><name><surname>Markowitz</surname><given-names>JS</given-names></name></person-group><article-title>Human monocytic ehrlichiosis: an emerging pathogen in transplantation</article-title><source>Transplantation</source><year>2001</year><volume>71</volume><fpage>1678</fpage><lpage>1680</lpage><pub-id pub-id-type="pmid">11435982</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sachdev</surname><given-names>SH</given-names></name><name><surname>Joshi</surname><given-names>V</given-names></name><name><surname>Cox</surname><given-names>ER</given-names></name><name><surname>Amoroso</surname><given-names>A</given-names></name><name><surname>Palekar</surname><given-names>S</given-names></name></person-group><article-title>Severe life-threatening Ehrlichia chaffeensis infections transmitted through solid organ transplantation</article-title><source>Transpl Infect Dis</source><year>2014</year><volume>16</volume><fpage>119</fpage><lpage>124</lpage><pub-id pub-id-type="pmid">24330198</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Regunath</surname><given-names>H</given-names></name><name><surname>Rojas-Moreno</surname><given-names>C</given-names></name><name><surname>Olano</surname><given-names>JP</given-names></name><name><surname>Hammer</surname><given-names>RD</given-names></name><name><surname>Salzer</surname><given-names>W</given-names></name></person-group><article-title>Early diagnosis of Ehrlichia ewingii infection in a lung transplant recipient by peripheral blood smear</article-title><source>Transpl Infect Dis</source><year>2017</year><volume>19</volume></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamilton</surname><given-names>KS</given-names></name><name><surname>Standaert</surname><given-names>SM</given-names></name><name><surname>Kinney</surname><given-names>MC</given-names></name></person-group><article-title>Characteristic peripheral blood findings in human ehrlichiosis</article-title><source>Mod Pathol</source><year>2004</year><volume>17</volume><fpage>512</fpage><lpage>517</lpage><pub-id pub-id-type="pmid">14976527</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorn</surname><given-names>HF</given-names></name><name><surname>Dickinson</surname><given-names>B</given-names></name><name><surname>Agarwal</surname><given-names>A</given-names></name><name><surname>Brayman</surname><given-names>KL</given-names></name></person-group><article-title>Human Ehrlichiosis after Treatment of Acute Cellular Rejection in a Kidney Transplant Patient</article-title><source>Transplantation</source><year>2012</year><volume>94</volume><fpage>531</fpage></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadikot</surname><given-names>R</given-names></name><name><surname>Shaver</surname><given-names>MJ</given-names></name><name><surname>Reeves</surname><given-names>WB</given-names></name></person-group><article-title>Ehrlichia chaffeensis in a renal transplant recipient</article-title><source>Am J Nephrol</source><year>1999</year><volume>19</volume><fpage>674</fpage><lpage>676</lpage><pub-id pub-id-type="pmid">10592362</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawrence</surname><given-names>KL</given-names></name><name><surname>Morrell</surname><given-names>MR</given-names></name><name><surname>Storch</surname><given-names>GA</given-names></name><name><surname>Hachem</surname><given-names>RR</given-names></name><name><surname>Trulock</surname><given-names>EP</given-names></name></person-group><article-title>Clinical outcomes of solid organ transplant recipients with ehrlichiosis</article-title><source>Transpl Infect Dis</source><year>2009</year><volume>11</volume><fpage>203</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">19228344</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>LD</given-names></name><name><surname>Hongo</surname><given-names>I</given-names></name><name><surname>Bloch</surname><given-names>KC</given-names></name><name><surname>Tang</surname><given-names>YW</given-names></name><name><surname>Dummer</surname><given-names>S</given-names></name></person-group><article-title>Human ehrlichiosis in transplant recipients</article-title><source>Am J Transplant</source><year>2007</year><volume>7</volume><fpage>1641</fpage><lpage>1647</lpage><pub-id pub-id-type="pmid">17511689</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cotant</surname><given-names>C</given-names></name><name><surname>Okulicz</surname><given-names>JF</given-names></name><name><surname>Brezina</surname><given-names>B</given-names></name><name><surname>Riley</surname><given-names>DJ</given-names></name><name><surname>Conger</surname><given-names>NG</given-names></name></person-group><article-title>Human monocytic ehrlichiosis in a renal transplant patient</article-title><source>Scand J Infect Dis</source><year>2006</year><volume>38</volume><fpage>699</fpage><lpage>702</lpage><pub-id pub-id-type="pmid">16857619</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liddell</surname><given-names>AM</given-names></name><name><surname>Sumner</surname><given-names>JW</given-names></name><name><surname>Paddock</surname><given-names>CD</given-names></name><name><surname>Rikihisa</surname><given-names>Y</given-names></name><name><surname>Unver</surname><given-names>A</given-names></name><name><surname>Buller</surname><given-names>RS</given-names></name><name><surname>Storch</surname><given-names>GA</given-names></name></person-group><article-title>Reinfection with Ehrlichia chaffeensis in a liver transplant recipient</article-title><source>Clin Infect Dis</source><year>2002</year><volume>34</volume><fpage>1644</fpage><lpage>1647</lpage><pub-id pub-id-type="pmid">12032902</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Safdar</surname><given-names>N</given-names></name><name><surname>Love</surname><given-names>RB</given-names></name><name><surname>Maki</surname><given-names>DG</given-names></name></person-group><article-title>Severe Ehrlichia chaffeensis infection in a lung transplant recipient: a review of ehrlichiosis in the immunocompromised patient</article-title><source>Emerg Infect Dis</source><year>2002</year><volume>8</volume><fpage>320</fpage><lpage>323</lpage><pub-id pub-id-type="pmid">11927032</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parola</surname><given-names>P</given-names></name><name><surname>Paddock</surname><given-names>CD</given-names></name><name><surname>Raoult</surname><given-names>D</given-names></name></person-group><article-title>Tick-borne rickettsioses around the world: emerging diseases challenging old concepts</article-title><source>Clin Microbiol Rev</source><year>2005</year><volume>18</volume><fpage>719</fpage><lpage>756</lpage><pub-id pub-id-type="pmid">16223955</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="webpage"><collab>European Centre for Disease Prevention and Control</collab><article-title>Epidemiological situation of rickettsioses in EU/EFTA countries. [accessed December 2019]</article-title><comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.ecdc.europa.eu/en/publications-data/epidemiological-situation-rickettsioses-euefta-countries">https://www.ecdc.europa.eu/en/publications-data/epidemiological-situation-rickettsioses-euefta-countries</ext-link></comment></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adem</surname><given-names>PV</given-names></name></person-group><article-title>Emerging and re-emerging rickettsial infections</article-title><source>Semin Diagn Pathol</source><year>2019</year><volume>36</volume><fpage>146</fpage><lpage>151</lpage><pub-id pub-id-type="pmid">31101391</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rallis</surname><given-names>TM</given-names></name><name><surname>Kriesel</surname><given-names>JD</given-names></name><name><surname>Dumler</surname><given-names>JS</given-names></name><name><surname>Wagoner</surname><given-names>LE</given-names></name><name><surname>Wright</surname><given-names>ED</given-names></name><name><surname>Spruance</surname><given-names>SL</given-names></name></person-group><article-title>Rocky Mountain spotted fever following cardiac transplantation</article-title><source>West J Med</source><year>1993</year><volume>158</volume><fpage>625</fpage><lpage>628</lpage><pub-id pub-id-type="pmid">8337866</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmulewitz</surname><given-names>L</given-names></name><name><surname>Moumile</surname><given-names>K</given-names></name><name><surname>Patey-Mariaud de Serre</surname><given-names>N</given-names></name><name><surname>Poir&#x000e9;e</surname><given-names>S</given-names></name><name><surname>Gouin</surname><given-names>E</given-names></name><name><surname>Mecha&#x000ef;</surname><given-names>F</given-names></name><name><surname>Cocard</surname><given-names>V</given-names></name><name><surname>Mamzer-Bruneel</surname><given-names>MF</given-names></name><name><surname>Abachin</surname><given-names>E</given-names></name><name><surname>Berche</surname><given-names>P</given-names></name><name><surname>Lortholary</surname><given-names>O</given-names></name><name><surname>Lecuit</surname><given-names>M</given-names></name></person-group><article-title>Splenic rupture and malignant Mediterranean spotted fever</article-title><source>Emerg Infect Dis</source><year>2008</year><volume>14</volume><fpage>995</fpage><lpage>997</lpage><pub-id pub-id-type="pmid">18507929</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakraborty</surname><given-names>S</given-names></name><name><surname>Sarma</surname><given-names>N</given-names></name></person-group><article-title>Scrub Typhus: An Emerging Threat</article-title><source>Indian J Dermatol</source><year>2017</year><volume>62</volume><fpage>478</fpage><lpage>485</lpage><pub-id pub-id-type="pmid">28979009</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhanapriya</surname><given-names>J</given-names></name><name><surname>Dineshkumar</surname><given-names>T</given-names></name><name><surname>Sakthirajan</surname><given-names>R</given-names></name><name><surname>Murugan</surname><given-names>S</given-names></name><name><surname>Jayaprakash</surname><given-names>V</given-names></name><name><surname>Balasubramaniyan</surname><given-names>T</given-names></name><name><surname>Gopalakrishnan</surname><given-names>N</given-names></name></person-group><article-title>Scrub typhus meningitis in a renal transplant recipient</article-title><source>Indian J Nephrol</source><year>2017</year><volume>27</volume><fpage>151</fpage><lpage>153</lpage><pub-id pub-id-type="pmid">28356672</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peter</surname><given-names>JV</given-names></name><name><surname>Sudarsan</surname><given-names>TI</given-names></name><name><surname>Prakash</surname><given-names>JA</given-names></name><name><surname>Varghese</surname><given-names>GM</given-names></name></person-group><article-title>Severe scrub typhus infection: Clinical features, diagnostic challenges and management</article-title><source>World J Crit Care Med</source><year>2015</year><volume>4</volume><fpage>244</fpage><lpage>250</lpage><pub-id pub-id-type="pmid">26261776</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luce-Fedrow</surname><given-names>A</given-names></name><name><surname>Lehman</surname><given-names>ML</given-names></name><name><surname>Kelly</surname><given-names>DJ</given-names></name><name><surname>Mullins</surname><given-names>K</given-names></name><name><surname>Maina</surname><given-names>AN</given-names></name><name><surname>Stewart</surname><given-names>RL</given-names></name><name><surname>Ge</surname><given-names>H</given-names></name><name><surname>John</surname><given-names>HS</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Richards</surname><given-names>AL</given-names></name></person-group><article-title>A Review of Scrub Typhus (Orientia tsutsugamushi and Related Organisms): Then, Now, and Tomorrow</article-title><source>Trop Med Infect Dis</source><year>2018</year><volume>3</volume></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balenghien</surname><given-names>T</given-names></name><name><surname>Cardinale</surname><given-names>E</given-names></name><name><surname>Chevalier</surname><given-names>V</given-names></name><name><surname>Elissa</surname><given-names>N</given-names></name><name><surname>Failloux</surname><given-names>AB</given-names></name><name><surname>Jean Jose Nipomichene</surname><given-names>TN</given-names></name><name><surname>Nicolas</surname><given-names>G</given-names></name><name><surname>Rakotoharinome</surname><given-names>VM</given-names></name><name><surname>Roger</surname><given-names>M</given-names></name><name><surname>Zumbo</surname><given-names>B</given-names></name></person-group><article-title>Towards a better understanding of Rift Valley fever epidemiology in the south-west of the Indian Ocean</article-title><source>Vet Res</source><year>2013</year><volume>44</volume><fpage>78</fpage><pub-id pub-id-type="pmid">24016237</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linthicum</surname><given-names>KJ</given-names></name><name><surname>Britch</surname><given-names>SC</given-names></name><name><surname>Anyamba</surname><given-names>A</given-names></name></person-group><article-title>Rift Valley Fever: An Emerging Mosquito-Borne Disease</article-title><source>Annu Rev Entomol</source><year>2016</year><volume>61</volume><fpage>395</fpage><lpage>415</lpage><pub-id pub-id-type="pmid">26982443</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>MHA</given-names></name><name><surname>Warimwe</surname><given-names>GM</given-names></name><name><surname>Di Nardo</surname><given-names>A</given-names></name><name><surname>Lyons</surname><given-names>NA</given-names></name><name><surname>Gubbins</surname><given-names>S</given-names></name></person-group><article-title>Systematic literature review of Rift Valley fever virus seroprevalence in livestock, wildlife and humans in Africa from 1968 to 2016</article-title><source>PLoS Negl Trop Dis</source><year>2018</year><volume>12</volume><fpage>e0006627</fpage><pub-id pub-id-type="pmid">30036382</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McMillen</surname><given-names>CM</given-names></name><name><surname>Hartman</surname><given-names>AL</given-names></name></person-group><article-title>Rift Valley fever in animals and humans: Current perspectives</article-title><source>Antiviral Res</source><year>2018</year><volume>156</volume><fpage>29</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">29857007</pub-id></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mansfield</surname><given-names>KL</given-names></name><name><surname>Banyard</surname><given-names>AC</given-names></name><name><surname>McElhinney</surname><given-names>L</given-names></name><name><surname>Johnson</surname><given-names>N</given-names></name><name><surname>Horton</surname><given-names>DL</given-names></name><name><surname>Hern&#x000e1;ndez-Triana</surname><given-names>LM</given-names></name><name><surname>Fooks</surname><given-names>AR</given-names></name></person-group><article-title>Rift Valley fever virus: A review of diagnosis and vaccination, and implications for emergence in Europe</article-title><source>Vaccine</source><year>2015</year><volume>33</volume><fpage>5520</fpage><lpage>5531</lpage><pub-id pub-id-type="pmid">26296499</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haneche</surname><given-names>F</given-names></name><name><surname>Leparc-Goffart</surname><given-names>I</given-names></name><name><surname>Simon</surname><given-names>F</given-names></name><name><surname>Hentzien</surname><given-names>M</given-names></name><name><surname>Martinez-Pourcher</surname><given-names>V</given-names></name><name><surname>Caumes</surname><given-names>E</given-names></name><name><surname>Maquart</surname><given-names>M</given-names></name></person-group><article-title>Rift Valley fever in kidney transplant recipient returning from Mali with viral RNA detected in semen up to four months from symptom onset, France, autumn 2015</article-title><source>Euro Surveill</source><year>2016</year><volume>21</volume></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diaz</surname><given-names>A</given-names></name><name><surname>Coffey</surname><given-names>LL</given-names></name><name><surname>Burkett-Cadena</surname><given-names>N</given-names></name><name><surname>Day</surname><given-names>JF</given-names></name></person-group><article-title>Reemergence of St. Louis Encephalitis Virus in the Americas</article-title><source>Emerg Infect Dis</source><year>2018</year><volume>24</volume></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>LV</given-names></name><name><surname>Graham</surname><given-names>C</given-names></name></person-group><article-title>Louis Encephalitis</article-title><comment>Treasure Island, FL: StatPearls Publishing, 2019</comment></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oyer</surname><given-names>RJ</given-names></name><name><surname>David Beckham</surname><given-names>J</given-names></name><name><surname>Tyler</surname><given-names>KL</given-names></name></person-group><article-title>West Nile and St. Louis encephalitis viruses</article-title><source>Handb Clin Neurol</source><year>2014</year><volume>123</volume><fpage>433</fpage><lpage>447</lpage><pub-id pub-id-type="pmid">25015498</pub-id></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartmann</surname><given-names>CA</given-names></name><name><surname>Vikram</surname><given-names>HR</given-names></name><name><surname>Seville</surname><given-names>MT</given-names></name><name><surname>Orenstein</surname><given-names>R</given-names></name><name><surname>Kusne</surname><given-names>S</given-names></name><name><surname>Blair</surname><given-names>JE</given-names></name><name><surname>Grys</surname><given-names>TE</given-names></name><name><surname>Patron</surname><given-names>RL</given-names></name></person-group><article-title>Neuroinvasive St. Louis Encephalitis Virus Infection in Solid Organ Transplant Recipients</article-title><source>Am J Transplant</source><year>2017</year><volume>17</volume><fpage>2200</fpage><lpage>2206</lpage><pub-id pub-id-type="pmid">28452107</pub-id></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duffy</surname><given-names>MR</given-names></name><name><surname>Chen</surname><given-names>TH</given-names></name><name><surname>Hancock</surname><given-names>WT</given-names></name><name><surname>Powers</surname><given-names>AM</given-names></name><name><surname>Kool</surname><given-names>JL</given-names></name><name><surname>Lanciotti</surname><given-names>RS</given-names></name><name><surname>Pretrick</surname><given-names>M</given-names></name><name><surname>Marfel</surname><given-names>M</given-names></name><name><surname>Holzbauer</surname><given-names>S</given-names></name><name><surname>Dubray</surname><given-names>C</given-names></name><name><surname>Guillaumot</surname><given-names>L</given-names></name><name><surname>Griggs</surname><given-names>A</given-names></name><name><surname>Bel</surname><given-names>M</given-names></name><name><surname>Lambert</surname><given-names>AJ</given-names></name><name><surname>Laven</surname><given-names>J</given-names></name><name><surname>Kosoy</surname><given-names>O</given-names></name><name><surname>Panella</surname><given-names>A</given-names></name><name><surname>Biggerstaff</surname><given-names>BJ</given-names></name><name><surname>Fischer</surname><given-names>M</given-names></name><name><surname>Hayes</surname><given-names>EB</given-names></name></person-group><article-title>Zika virus outbreak on Yap Island, Federated States of Micronesia</article-title><source>N Engl J Med</source><year>2009</year><volume>360</volume><fpage>2536</fpage><lpage>2543</lpage><pub-id pub-id-type="pmid">19516034</pub-id></element-citation></ref><ref id="B67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noorbakhsh</surname><given-names>F</given-names></name><name><surname>Abdolmohammadi</surname><given-names>K</given-names></name><name><surname>Fatahi</surname><given-names>Y</given-names></name><name><surname>Dalili</surname><given-names>H</given-names></name><name><surname>Rasoolinejad</surname><given-names>M</given-names></name><name><surname>Rezaei</surname><given-names>F</given-names></name><name><surname>Salehi-Vaziri</surname><given-names>M</given-names></name><name><surname>Shafiei-Jandaghi</surname><given-names>NZ</given-names></name><name><surname>Gooshki</surname><given-names>ES</given-names></name><name><surname>Zaim</surname><given-names>M</given-names></name><name><surname>Nicknam</surname><given-names>MH</given-names></name></person-group><article-title>Zika Virus Infection, Basic and Clinical Aspects: A Review Article</article-title><source>Iran J Public Health</source><year>2019</year><volume>48</volume><fpage>20</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">30847308</pub-id></element-citation></ref><ref id="B68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez-Morales</surname><given-names>AJ</given-names></name><name><surname>Bandeira</surname><given-names>AC</given-names></name><name><surname>Franco-Paredes</surname><given-names>C</given-names></name></person-group><article-title>The expanding spectrum of modes of transmission of Zika virus: a global concern</article-title><source>Ann Clin Microbiol Antimicrob</source><year>2016</year><volume>15</volume><fpage>13</fpage><pub-id pub-id-type="pmid">26939897</pub-id></element-citation></ref><ref id="B69"><label>69</label><element-citation publication-type="journal"><collab>European Centre for Disease Prevention and Control (ECDC)</collab><article-title>Laboratory tests for Zika virus diagnostic</article-title><comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.ecdc.europa.eu/en/publications-data/laboratory-tests-zika-virus-diagnostic">https://www.ecdc.europa.eu/en/publications-data/laboratory-tests-zika-virus-diagnostic</ext-link></comment></element-citation></ref><ref id="B70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>JK</given-names></name><name><surname>Castellani</surname><given-names>L</given-names></name><name><surname>Lecce</surname><given-names>C</given-names></name><name><surname>Khatib</surname><given-names>A</given-names></name><name><surname>Bonta</surname><given-names>M</given-names></name><name><surname>Boggild</surname><given-names>AK</given-names></name></person-group><article-title>Zika Virus-Associated Aseptic Meningitis and Guillain-Barre Syndrome in a Traveler Returning from Latin America: a Case Report and Mini-Review</article-title><source>Curr Infect Dis Rep</source><year>2019</year><volume>21</volume><fpage>3</fpage><pub-id pub-id-type="pmid">30767073</pub-id></element-citation></ref><ref id="B71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nogueira</surname><given-names>ML</given-names></name><name><surname>Estofolete</surname><given-names>CF</given-names></name><name><surname>Terzian</surname><given-names>AC</given-names></name><name><surname>Mascarin do Vale</surname><given-names>EP</given-names></name><name><surname>da Silva</surname><given-names>RC</given-names></name><name><surname>da Silva</surname><given-names>RF</given-names></name><name><surname>Ramalho</surname><given-names>HJ</given-names></name><name><surname>Fernandes Charpiot</surname><given-names>IM</given-names></name><name><surname>Vasilakis</surname><given-names>N</given-names></name><name><surname>Abbud-Filho</surname><given-names>M</given-names></name></person-group><article-title>Zika Virus Infection and Solid Organ Transplantation: A New Challenge</article-title><source>Am J Transplant</source><year>2017</year><volume>17</volume><fpage>791</fpage><lpage>795</lpage><pub-id pub-id-type="pmid">27629942</pub-id></element-citation></ref><ref id="B72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vairo</surname><given-names>F</given-names></name><name><surname>Haider</surname><given-names>N</given-names></name><name><surname>Kock</surname><given-names>R</given-names></name><name><surname>Ntoumi</surname><given-names>F</given-names></name><name><surname>Ippolito</surname><given-names>G</given-names></name><name><surname>Zumla</surname><given-names>A</given-names></name></person-group><article-title>Chikungunya: Epidemiology, Pathogenesis, Clinical Features, Management, and Prevention</article-title><source>Infect Dis Clin North Am</source><year>2019</year><volume>33</volume><fpage>1003</fpage><lpage>1025</lpage><pub-id pub-id-type="pmid">31668189</pub-id></element-citation></ref><ref id="B73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganesan</surname><given-names>VK</given-names></name><name><surname>Duan</surname><given-names>B</given-names></name><name><surname>Reid</surname><given-names>SP</given-names></name></person-group><article-title>Chikungunya Virus: Pathophysiology, Mechanism, and Modeling</article-title><source>Viruses</source><year>2017</year><volume>9</volume></element-citation></ref><ref id="B74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Economopoulou</surname><given-names>A</given-names></name><name><surname>Dominguez</surname><given-names>M</given-names></name><name><surname>Helynck</surname><given-names>B</given-names></name><name><surname>Sissoko</surname><given-names>D</given-names></name><name><surname>Wichmann</surname><given-names>O</given-names></name><name><surname>Quenel</surname><given-names>P</given-names></name><name><surname>Germonneau</surname><given-names>P</given-names></name><name><surname>Quatresous</surname><given-names>I</given-names></name></person-group><article-title>Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005-2006 outbreak on R&#x000e9;union</article-title><source>Epidemiol Infect</source><year>2009</year><volume>137</volume><fpage>534</fpage><lpage>541</lpage><pub-id pub-id-type="pmid">18694529</pub-id></element-citation></ref><ref id="B75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonifay</surname><given-names>T</given-names></name><name><surname>Prince</surname><given-names>C</given-names></name><name><surname>Neyra</surname><given-names>C</given-names></name><name><surname>Demar</surname><given-names>M</given-names></name><name><surname>Rousset</surname><given-names>D</given-names></name><name><surname>Kallel</surname><given-names>H</given-names></name><name><surname>Nacher</surname><given-names>M</given-names></name><name><surname>Djossou</surname><given-names>F</given-names></name><name><surname>Epelboin</surname><given-names>L</given-names></name></person-group><collab>Char Chik Working group</collab><article-title>Atypical and severe manifestations of chikungunya virus infection in French Guiana: A hospital-based study</article-title><source>PLoS One</source><year>2018</year><volume>13</volume><fpage>e0207406</fpage><pub-id pub-id-type="pmid">30521555</pub-id></element-citation></ref><ref id="B76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalla Gasperina</surname><given-names>D</given-names></name><name><surname>Balsamo</surname><given-names>ML</given-names></name><name><surname>Garavaglia</surname><given-names>SD</given-names></name><name><surname>Rovida</surname><given-names>F</given-names></name><name><surname>Baldanti</surname><given-names>F</given-names></name><name><surname>Grossi</surname><given-names>PA</given-names></name></person-group><article-title>Chikungunya infection in a human immunodeficiency virus-infected kidney transplant recipient returning to Italy from the Dominican Republic</article-title><source>Transpl Infect Dis</source><year>2015</year><volume>17</volume><fpage>876</fpage><lpage>879</lpage><pub-id pub-id-type="pmid">26771689</pub-id></element-citation></ref><ref id="B77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pierrotti</surname><given-names>LC</given-names></name><name><surname>Lopes</surname><given-names>MIBF</given-names></name><name><surname>Nascimento</surname><given-names>APD</given-names></name><name><surname>Caiaffa-Filho</surname><given-names>H</given-names></name><name><surname>Lemos</surname><given-names>FBC</given-names></name><name><surname>Reusing</surname><given-names>JO</given-names><suffix>Jr</suffix></name><name><surname>Sejas</surname><given-names>ONE</given-names></name><name><surname>David-Neto</surname><given-names>E</given-names></name><name><surname>Azevedo</surname><given-names>LS</given-names></name></person-group><article-title>Chikungunya in kidney transplant recipients: A series of cases</article-title><source>Int J Infect Dis</source><year>2017</year><volume>64</volume><fpage>96</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">28941631</pub-id></element-citation></ref><ref id="B78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosso</surname><given-names>F</given-names></name><name><surname>Rodr&#x000ed;guez</surname><given-names>S</given-names></name><name><surname>Cedano</surname><given-names>JA</given-names></name><name><surname>Mora</surname><given-names>BL</given-names></name><name><surname>Moncada</surname><given-names>PA</given-names></name><name><surname>Velez</surname><given-names>JD</given-names></name></person-group><article-title>Chikungunya in solid organ transplant recipients, a case series and literature review</article-title><source>Transpl Infect Dis</source><year>2018</year><volume>20</volume><fpage>e12978</fpage><pub-id pub-id-type="pmid">30120808</pub-id></element-citation></ref><ref id="B79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foresto</surname><given-names>RD</given-names></name><name><surname>Santos</surname><given-names>DWCL</given-names></name><name><surname>Hazin</surname><given-names>MAA</given-names></name><name><surname>Leyton</surname><given-names>ATZ</given-names></name><name><surname>Ten&#x000f3;rio</surname><given-names>NC</given-names></name><name><surname>Viana</surname><given-names>LA</given-names></name><name><surname>Cristelli</surname><given-names>MP</given-names></name><name><surname>Silva J&#x000fa;nior</surname><given-names>HT</given-names></name><name><surname>Pestana</surname><given-names>JOM</given-names></name></person-group><article-title>Chikungunya in a kidney transplant recipient: a case report</article-title><source>J Bras Nefrol</source><year>2019</year><volume>41</volume><fpage>575</fpage><lpage>579</lpage><pub-id pub-id-type="pmid">31419273</pub-id></element-citation></ref><ref id="B80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gir&#x000e3;o</surname><given-names>ES</given-names></name><name><surname>Rodrigues Dos Santos</surname><given-names>BG</given-names></name><name><surname>do Amaral</surname><given-names>ES</given-names></name><name><surname>Costa</surname><given-names>PEG</given-names></name><name><surname>Pereira</surname><given-names>KB</given-names></name><name><surname>de Araujo Filho</surname><given-names>AH</given-names></name><name><surname>Hyppolito</surname><given-names>EB</given-names></name><name><surname>Mota</surname><given-names>MU</given-names></name><name><surname>Marques</surname><given-names>LCBF</given-names></name><name><surname>Costa de Oliveira</surname><given-names>CM</given-names></name><name><surname>da Silva</surname><given-names>SL</given-names></name><name><surname>Garcia</surname><given-names>JHP</given-names></name><name><surname>Fernandes</surname><given-names>PFCBC</given-names></name></person-group><article-title>Chikungunya Infection in Solid Organ Transplant Recipients</article-title><source>Transplant Proc</source><year>2017</year><volume>49</volume><fpage>2076</fpage><lpage>2081</lpage><pub-id pub-id-type="pmid">29149964</pub-id></element-citation></ref><ref id="B81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>RK</given-names></name><name><surname>Gupta</surname><given-names>G</given-names></name><name><surname>Chorasiya</surname><given-names>VK</given-names></name><name><surname>Bag</surname><given-names>P</given-names></name><name><surname>Shandil</surname><given-names>R</given-names></name><name><surname>Bhatia</surname><given-names>V</given-names></name><name><surname>Wadhawan</surname><given-names>M</given-names></name><name><surname>Vij</surname><given-names>V</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name></person-group><article-title>Dengue Virus Transmission from Living Donor to Recipient in Liver Transplantation: A Case Report</article-title><source>J Clin Exp Hepatol</source><year>2016</year><volume>6</volume><fpage>59</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">27194898</pub-id></element-citation></ref><ref id="B82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalayanarooj</surname><given-names>S</given-names></name></person-group><article-title>Clinical Manifestations and Management of Dengue/DHF/DSS</article-title><source>Trop Med Health</source><year>2011</year><volume>39</volume><fpage>83</fpage><lpage>87</lpage></element-citation></ref><ref id="B83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>DA</given-names></name><name><surname>Depelsenaire</surname><given-names>AC</given-names></name><name><surname>Young</surname><given-names>PR</given-names></name></person-group><article-title>Clinical and Laboratory Diagnosis of Dengue Virus Infection</article-title><source>J Infect Dis</source><year>2017</year><volume>215</volume><fpage>S89</fpage><lpage>S95</lpage><pub-id pub-id-type="pmid">28403441</pub-id></element-citation></ref><ref id="B84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nasim</surname><given-names>A</given-names></name><name><surname>Anis</surname><given-names>S</given-names></name><name><surname>Baqi</surname><given-names>S</given-names></name><name><surname>Akhtar</surname><given-names>SF</given-names></name><name><surname>Baig-Ansari</surname><given-names>N</given-names></name></person-group><article-title>Clinical presentation and outcome of dengue viral infection in live-related renal transplant recipients in Karachi, Pakistan</article-title><source>Transpl Infect Dis</source><year>2013</year><volume>15</volume><fpage>516</fpage><lpage>525</lpage><pub-id pub-id-type="pmid">23890225</pub-id></element-citation></ref><ref id="B85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maia</surname><given-names>SH</given-names></name><name><surname>Brasil</surname><given-names>IR</given-names></name><name><surname>Esmeraldo Rde</surname><given-names>M</given-names></name><name><surname>Ponte</surname><given-names>CN</given-names></name><name><surname>Costa</surname><given-names>RC</given-names></name><name><surname>Lira</surname><given-names>RA</given-names></name></person-group><article-title>Severe dengue in the early postoperative period after kidney transplantation: two case reports from Hospital Geral de Fortaleza</article-title><source>Rev Soc Bras Med Trop</source><year>2015</year><volume>48</volume><fpage>783</fpage><lpage>785</lpage><pub-id pub-id-type="pmid">26676509</pub-id></element-citation></ref><ref id="B86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weerakkody</surname><given-names>RM</given-names></name><name><surname>Palangasinghe</surname><given-names>DR</given-names></name><name><surname>Wijewickrama</surname><given-names>ES</given-names></name></person-group><article-title>Dengue fever in a kidney transplant recipient with complicated clinical course: a case report</article-title><source>J Med Case Rep</source><year>2018</year><volume>12</volume><fpage>260</fpage><pub-id pub-id-type="pmid">30170627</pub-id></element-citation></ref><ref id="B87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinsai</surname><given-names>S</given-names></name><name><surname>Kiertiburanakul</surname><given-names>S</given-names></name><name><surname>Watcharananan</surname><given-names>SP</given-names></name><name><surname>Kantachuvessiri</surname><given-names>S</given-names></name><name><surname>Boongird</surname><given-names>S</given-names></name><name><surname>Bruminhent</surname><given-names>J</given-names></name></person-group><article-title>Epidemiology and outcomes of dengue in kidney transplant recipients: A 20-year retrospective analysis and comparative literature review</article-title><source>Clin Transplant</source><year>2019</year><volume>33</volume><fpage>e13458</fpage><pub-id pub-id-type="pmid">30506903</pub-id></element-citation></ref><ref id="B88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosso</surname><given-names>F</given-names></name><name><surname>Sanz</surname><given-names>AM</given-names></name><name><surname>Parra-Lara</surname><given-names>LG</given-names></name><name><surname>Moncada</surname><given-names>PA</given-names></name><name><surname>V&#x000e9;lez</surname><given-names>JD</given-names></name><name><surname>Caicedo</surname><given-names>LA</given-names></name></person-group><article-title>Dengue Virus Infection in Solid Organ Transplant Recipients: A Case Series and Literature Review</article-title><source>Am J Trop Med Hyg</source><year>2019</year><volume>101</volume><fpage>1226</fpage><lpage>1231</lpage><pub-id pub-id-type="pmid">31628736</pub-id></element-citation></ref><ref id="B89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kenwar</surname><given-names>D</given-names></name><name><surname>Kallepalli</surname><given-names>V</given-names></name><name><surname>Sharma</surname><given-names>A</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Singh</surname><given-names>N</given-names></name><name><surname>Kapoor</surname><given-names>K</given-names></name><name><surname>Chamb</surname><given-names>S</given-names></name></person-group><article-title>Dengue in the Renal Transplant Population - A Single Center Experience</article-title><source>Transplantation</source><year>2018</year><volume>102</volume><fpage>663</fpage></element-citation></ref><ref id="B90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaji Mathew</surname><given-names>J</given-names></name><name><surname>Menon</surname><given-names>V</given-names></name><name><surname>Surendran</surname><given-names>S</given-names></name></person-group><article-title>Dengue virus transmission from live donor liver graft: Comments and clarifications</article-title><source>Am J Transplant</source><year>2019</year><volume>19</volume><fpage>2140</fpage><pub-id pub-id-type="pmid">30768850</pub-id></element-citation></ref><ref id="B91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosso</surname><given-names>F</given-names></name><name><surname>Pineda</surname><given-names>JC</given-names></name><name><surname>Sanz</surname><given-names>AM</given-names></name><name><surname>Cedano</surname><given-names>JA</given-names></name><name><surname>Caicedo</surname><given-names>LA</given-names></name></person-group><article-title>Transmission of dengue virus from deceased donors to solid organ transplant recipients: case report and literature review</article-title><source>Braz J Infect Dis</source><year>2018</year><volume>22</volume><fpage>63</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">29353669</pub-id></element-citation></ref><ref id="B92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cedano</surname><given-names>JA</given-names></name><name><surname>Mora</surname><given-names>BL</given-names></name><name><surname>Parra-Lara</surname><given-names>LG</given-names></name><name><surname>Manzano-Nu&#x000f1;ez</surname><given-names>R</given-names></name><name><surname>Rosso</surname><given-names>F</given-names></name></person-group><article-title>A scoping review of transmission of dengue virus from donors to recipients after solid organ transplantation</article-title><source>Trans R Soc Trop Med Hyg</source><year>2019</year><volume>113</volume><fpage>431</fpage><lpage>436</lpage><pub-id pub-id-type="pmid">31034049</pub-id></element-citation></ref><ref id="B93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janani</surname><given-names>MK</given-names></name><name><surname>Durgadevi</surname><given-names>P</given-names></name><name><surname>Padmapriya</surname><given-names>J</given-names></name><name><surname>Malathi</surname><given-names>J</given-names></name><name><surname>Kulandai</surname><given-names>LT</given-names></name><name><surname>Rao Madhavan</surname><given-names>HN</given-names></name></person-group><article-title>First Report on Detection of Dengue Virus in the Donor Cornea</article-title><source>Cornea</source><year>2018</year><volume>37</volume><fpage>1586</fpage><lpage>1589</lpage><pub-id pub-id-type="pmid">30272614</pub-id></element-citation></ref><ref id="B94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zannoli</surname><given-names>S</given-names></name><name><surname>Sambri</surname><given-names>V</given-names></name></person-group><article-title>West Nile Virus and Usutu Virus Co-Circulation in Europe: Epidemiology and Implications</article-title><source>Microorganisms</source><year>2019</year><volume>7</volume></element-citation></ref><ref id="B95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sejvar</surname><given-names>JJ</given-names></name></person-group><article-title>Clinical manifestations and outcomes of West Nile virus infection</article-title><source>Viruses</source><year>2014</year><volume>6</volume><fpage>606</fpage><lpage>623</lpage><pub-id pub-id-type="pmid">24509812</pub-id></element-citation></ref><ref id="B96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Gennaro</surname><given-names>A</given-names></name><name><surname>Lorusso</surname><given-names>A</given-names></name><name><surname>Casaccia</surname><given-names>C</given-names></name><name><surname>Conte</surname><given-names>A</given-names></name><name><surname>Monaco</surname><given-names>F</given-names></name><name><surname>Savini</surname><given-names>G</given-names></name></person-group><article-title>Serum neutralization assay can efficiently replace plaque reduction neutralization test for detection and quantitation of West Nile virus antibodies in human and animal serum samples</article-title><source>Clin Vaccine Immunol</source><year>2014</year><volume>21</volume><fpage>1460</fpage><lpage>1462</lpage><pub-id pub-id-type="pmid">25100824</pub-id></element-citation></ref><ref id="B97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vilibic-Cavlek</surname><given-names>T</given-names></name><name><surname>Kristofic</surname><given-names>B</given-names></name><name><surname>Savic</surname><given-names>V</given-names></name><name><surname>Kolaric</surname><given-names>B</given-names></name><name><surname>Barbic</surname><given-names>L</given-names></name><name><surname>Tabain</surname><given-names>I</given-names></name><name><surname>Peric</surname><given-names>L</given-names></name><name><surname>Sabadi</surname><given-names>D</given-names></name><name><surname>Miklausic</surname><given-names>B</given-names></name><name><surname>Potocnik-Hunjadi</surname><given-names>T</given-names></name><name><surname>Zember</surname><given-names>S</given-names></name><name><surname>Stevanovic</surname><given-names>V</given-names></name><name><surname>Listes</surname><given-names>E</given-names></name><name><surname>Savini</surname><given-names>G</given-names></name></person-group><article-title>Diagnostic significance of immunoglobulin G avidity in symptomatic and asymptomatic West Nile virus infection</article-title><source>Rev Soc Bras Med Trop</source><year>2018</year><volume>51</volume><fpage>591</fpage><lpage>595</lpage><pub-id pub-id-type="pmid">30304263</pub-id></element-citation></ref><ref id="B98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zanoni</surname><given-names>F</given-names></name><name><surname>Alfieri</surname><given-names>C</given-names></name><name><surname>Moroni</surname><given-names>G</given-names></name><name><surname>Passerini</surname><given-names>P</given-names></name><name><surname>Regalia</surname><given-names>A</given-names></name><name><surname>Meneghini</surname><given-names>M</given-names></name><name><surname>Messa</surname><given-names>P</given-names></name></person-group><article-title>Delayed Diagnosis of West Nile Virus Infection in a Kidney Transplant Patient Due to Inaccuracies in Commonly Available Diagnostic Tests</article-title><source>Experimental and Clinical Transplantation</source><year>2018</year><volume>1</volume><pub-id pub-id-type="doi">10.6002/ect.2018.0107</pub-id></element-citation></ref><ref id="B99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anesi</surname><given-names>JA</given-names></name><name><surname>Silveira</surname><given-names>FP</given-names></name></person-group><collab>AST Infectious Diseases Community of Practice</collab><article-title>Arenaviruses and West Nile Virus in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice</article-title><source>Clin Transplant</source><year>2019</year><volume>33</volume><fpage>e13576</fpage><pub-id pub-id-type="pmid">31022306</pub-id></element-citation></ref><ref id="B100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwamoto</surname><given-names>M</given-names></name><name><surname>Jernigan</surname><given-names>DB</given-names></name><name><surname>Guasch</surname><given-names>A</given-names></name><name><surname>Trepka</surname><given-names>MJ</given-names></name><name><surname>Blackmore</surname><given-names>CG</given-names></name><name><surname>Hellinger</surname><given-names>WC</given-names></name><name><surname>Pham</surname><given-names>SM</given-names></name><name><surname>Zaki</surname><given-names>S</given-names></name><name><surname>Lanciotti</surname><given-names>RS</given-names></name><name><surname>Lance-Parker</surname><given-names>SE</given-names></name><name><surname>DiazGranados</surname><given-names>CA</given-names></name><name><surname>Winquist</surname><given-names>AG</given-names></name><name><surname>Perlino</surname><given-names>CA</given-names></name><name><surname>Wiersma</surname><given-names>S</given-names></name><name><surname>Hillyer</surname><given-names>KL</given-names></name><name><surname>Goodman</surname><given-names>JL</given-names></name><name><surname>Marfin</surname><given-names>AA</given-names></name><name><surname>Chamberland</surname><given-names>ME</given-names></name><name><surname>Petersen</surname><given-names>LR</given-names></name></person-group><collab>West Nile Virus in Transplant Recipients Investigation Team</collab><article-title>Transmission of West Nile virus from an organ donor to four transplant recipients</article-title><source>N Engl J Med</source><year>2003</year><volume>348</volume><fpage>2196</fpage><lpage>2203</lpage><pub-id pub-id-type="pmid">12773646</pub-id></element-citation></ref><ref id="B101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardinger</surname><given-names>KL</given-names></name><name><surname>Miller</surname><given-names>B</given-names></name><name><surname>Storch</surname><given-names>GA</given-names></name><name><surname>Desai</surname><given-names>NM</given-names></name><name><surname>Brennan</surname><given-names>DC</given-names></name></person-group><article-title>West Nile virus-associated meningoencephalitis in two chronically immunosuppressed renal transplant recipients</article-title><source>Am J Transplant</source><year>2003</year><volume>3</volume><fpage>1312</fpage><lpage>1315</lpage><pub-id pub-id-type="pmid">14510707</pub-id></element-citation></ref><ref id="B102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleinschmidt-DeMasters</surname><given-names>BK</given-names></name><name><surname>Marder</surname><given-names>BA</given-names></name><name><surname>Levi</surname><given-names>ME</given-names></name><name><surname>Laird</surname><given-names>SP</given-names></name><name><surname>McNutt</surname><given-names>JT</given-names></name><name><surname>Escott</surname><given-names>EJ</given-names></name><name><surname>Everson</surname><given-names>GT</given-names></name><name><surname>Tyler</surname><given-names>KL</given-names></name></person-group><article-title>Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features</article-title><source>Arch Neurol</source><year>2004</year><volume>61</volume><fpage>1210</fpage><lpage>1220</lpage><pub-id pub-id-type="pmid">15313837</pub-id></element-citation></ref><ref id="B103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeSalvo</surname><given-names>D</given-names></name><name><surname>Roy-Chaudhury</surname><given-names>P</given-names></name><name><surname>Peddi</surname><given-names>R</given-names></name><name><surname>Merchen</surname><given-names>T</given-names></name><name><surname>Konijetti</surname><given-names>K</given-names></name><name><surname>Gupta</surname><given-names>M</given-names></name><name><surname>Boardman</surname><given-names>R</given-names></name><name><surname>Rogers</surname><given-names>C</given-names></name><name><surname>Buell</surname><given-names>J</given-names></name><name><surname>Hanaway</surname><given-names>M</given-names></name><name><surname>Broderick</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>R</given-names></name><name><surname>Woodle</surname><given-names>ES</given-names></name></person-group><article-title>West Nile virus encephalitis in organ transplant recipients: another high-risk group for meningoencephalitis and death</article-title><source>Transplantation</source><year>2004</year><volume>77</volume><fpage>466</fpage><lpage>469</lpage><pub-id pub-id-type="pmid">14966429</pub-id></element-citation></ref><ref id="B104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ravindra</surname><given-names>KV</given-names></name><name><surname>Freifeld</surname><given-names>AG</given-names></name><name><surname>Kalil</surname><given-names>AC</given-names></name><name><surname>Mercer</surname><given-names>DF</given-names></name><name><surname>Grant</surname><given-names>WJ</given-names></name><name><surname>Botha</surname><given-names>JF</given-names></name><name><surname>Wrenshall</surname><given-names>LE</given-names></name><name><surname>Stevens</surname><given-names>RB</given-names></name></person-group><article-title>West Nile virus-associated encephalitis in recipients of renal and pancreas transplants: case series and literature review</article-title><source>Clin Infect Dis</source><year>2004</year><volume>38</volume><fpage>1257</fpage><lpage>1260</lpage><pub-id pub-id-type="pmid">15127337</pub-id></element-citation></ref><ref id="B105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bragin-S&#x000e1;nchez</surname><given-names>D</given-names></name><name><surname>Chang</surname><given-names>PP</given-names></name></person-group><article-title>West Nile virus encephalitis infection in a heart transplant recipient: a case report</article-title><source>J Heart Lung Transplant</source><year>2005</year><volume>24</volume><fpage>621</fpage><lpage>623</lpage><pub-id pub-id-type="pmid">15896763</pub-id></element-citation></ref><ref id="B106"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>N</given-names></name><name><surname>Fisk</surname><given-names>D</given-names></name><name><surname>Sotir</surname><given-names>M</given-names></name><name><surname>Kehl</surname><given-names>KS</given-names></name></person-group><article-title>West Nile encephalitis, status epilepticus and West Nile pneumonia in a renal transplant patient</article-title><source>Transpl Int</source><year>2007</year><volume>20</volume><fpage>800</fpage><lpage>803</lpage><pub-id pub-id-type="pmid">17630998</pub-id></element-citation></ref><ref id="B107"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inojosa</surname><given-names>WO</given-names></name><name><surname>Scotton</surname><given-names>PG</given-names></name><name><surname>Fuser</surname><given-names>R</given-names></name><name><surname>Giobbia</surname><given-names>M</given-names></name><name><surname>Paolin</surname><given-names>A</given-names></name><name><surname>Maresca</surname><given-names>MC</given-names></name><name><surname>Brunello</surname><given-names>A</given-names></name><name><surname>Nascimben</surname><given-names>E</given-names></name><name><surname>Sorbara</surname><given-names>C</given-names></name><name><surname>Rigoli</surname><given-names>R</given-names></name><name><surname>Berti</surname><given-names>R</given-names></name><name><surname>Gajo</surname><given-names>GB</given-names></name><name><surname>Giometto</surname><given-names>B</given-names></name></person-group><article-title>West Nile virus transmission through organ transplantation in north-eastern Italy: a case report and implications for pre-procurement screening</article-title><source>Infection</source><year>2012</year><volume>40</volume><fpage>557</fpage><lpage>562</lpage><pub-id pub-id-type="pmid">22544764</pub-id></element-citation></ref><ref id="B108"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winston</surname><given-names>DJ</given-names></name><name><surname>Vikram</surname><given-names>HR</given-names></name><name><surname>Rabe</surname><given-names>IB</given-names></name><name><surname>Dhillon</surname><given-names>G</given-names></name><name><surname>Mulligan</surname><given-names>D</given-names></name><name><surname>Hong</surname><given-names>JC</given-names></name><name><surname>Busuttil</surname><given-names>RW</given-names></name><name><surname>Nowicki</surname><given-names>MJ</given-names></name><name><surname>Mone</surname><given-names>T</given-names></name><name><surname>Civen</surname><given-names>R</given-names></name><name><surname>Tecle</surname><given-names>SA</given-names></name><name><surname>Trivedi</surname><given-names>KK</given-names></name><name><surname>Hocevar</surname><given-names>SN</given-names></name></person-group><collab>West Nile Virus Transplant-Associated Transmission Investigation Team</collab><article-title>Donor-derived West Nile virus infection in solid organ transplant recipients: report of four additional cases and review of clinical, diagnostic, and therapeutic features</article-title><source>Transplantation</source><year>2014</year><volume>97</volume><fpage>881</fpage><lpage>889</lpage><pub-id pub-id-type="pmid">24827763</pub-id></element-citation></ref><ref id="B109"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>E</given-names></name><name><surname>Morris</surname><given-names>K</given-names></name><name><surname>Sodhi</surname><given-names>G</given-names></name><name><surname>Chang</surname><given-names>D</given-names></name><name><surname>Czer</surname><given-names>L</given-names></name><name><surname>Chung</surname><given-names>J</given-names></name><name><surname>Zabner</surname><given-names>R</given-names></name><name><surname>Raastad</surname><given-names>K</given-names></name><name><surname>Klapper</surname><given-names>E</given-names></name><name><surname>Kobashigawa</surname><given-names>J</given-names></name><name><surname>Nurok</surname><given-names>M</given-names></name></person-group><article-title>Neuroinvasive West Nile Virus Post-Heart Transplantation: A Case Report</article-title><source>Transplant Proc</source><year>2018</year><volume>50</volume><fpage>4057</fpage><lpage>4061</lpage><pub-id pub-id-type="pmid">30577314</pub-id></element-citation></ref><ref id="B110"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rabe</surname><given-names>IB</given-names></name><name><surname>Schwartz</surname><given-names>BS</given-names></name><name><surname>Farnon</surname><given-names>EC</given-names></name><name><surname>Josephson</surname><given-names>SA</given-names></name><name><surname>Webber</surname><given-names>AB</given-names></name><name><surname>Roberts</surname><given-names>JP</given-names></name><name><surname>de Mattos</surname><given-names>AM</given-names></name><name><surname>Gallay</surname><given-names>BJ</given-names></name><name><surname>van Slyck</surname><given-names>S</given-names></name><name><surname>Messenger</surname><given-names>SL</given-names></name><name><surname>Yen</surname><given-names>CJ</given-names></name><name><surname>Bloch</surname><given-names>EM</given-names></name><name><surname>Drew</surname><given-names>CP</given-names></name><name><surname>Fischer</surname><given-names>M</given-names></name><name><surname>Glaser</surname><given-names>CA</given-names></name></person-group><collab>WNV Transplant Investigation Team</collab><article-title>Fatal transplant-associated west nile virus encephalitis and public health investigation-california, 2010</article-title><source>Transplantation</source><year>2013</year><volume>96</volume><fpage>463</fpage><lpage>468</lpage><pub-id pub-id-type="pmid">23823653</pub-id></element-citation></ref><ref id="B111"><label>111</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francisco</surname><given-names>AM</given-names></name><name><surname>Glaser</surname><given-names>C</given-names></name><name><surname>Frykman</surname><given-names>E</given-names></name><name><surname>Cole</surname><given-names>B</given-names></name><name><surname>Cheung</surname><given-names>M</given-names></name><name><surname>Meyers</surname><given-names>H</given-names></name><name><surname>Ginsberg</surname><given-names>M</given-names></name><name><surname>Deckert</surname><given-names>A</given-names></name><name><surname>Jean</surname><given-names>C</given-names></name><name><surname>Jinadu</surname><given-names>BA</given-names></name></person-group><article-title>2004 California pediatric West Nile virus case series</article-title><source>Pediatr Infect Dis J</source><year>2006</year><volume>25</volume><fpage>81</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">16395112</pub-id></element-citation></ref><ref id="B112"><label>112</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambert</surname><given-names>SL</given-names></name><name><surname>Aviles</surname><given-names>D</given-names></name><name><surname>Vehaskari</surname><given-names>VM</given-names></name><name><surname>Ashoor</surname><given-names>IF</given-names></name></person-group><article-title>Severe West Nile virus meningoencephalitis in a pediatric renal transplant recipient: successful recovery and long-term neuropsychological outcome</article-title><source>Pediatr Transplant</source><year>2016</year><volume>20</volume><fpage>836</fpage><lpage>839</lpage><pub-id pub-id-type="pmid">27470315</pub-id></element-citation></ref><ref id="B113"><label>113</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weissenb&#x000f6;ck</surname><given-names>H</given-names></name><name><surname>Bakonyi</surname><given-names>T</given-names></name><name><surname>Rossi</surname><given-names>G</given-names></name><name><surname>Mani</surname><given-names>P</given-names></name><name><surname>Nowotny</surname><given-names>N</given-names></name></person-group><article-title>Usutu virus, Italy, 1996</article-title><source>Emerg Infect Dis</source><year>2013</year><volume>19</volume><fpage>274</fpage><lpage>277</lpage><pub-id pub-id-type="pmid">23347844</pub-id></element-citation></ref><ref id="B114"><label>114</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vilibic-Cavlek</surname><given-names>T</given-names></name><name><surname>Kaic</surname><given-names>B</given-names></name><name><surname>Barbic</surname><given-names>L</given-names></name><name><surname>Pem-Novosel</surname><given-names>I</given-names></name><name><surname>Slavic-Vrzic</surname><given-names>V</given-names></name><name><surname>Lesnikar</surname><given-names>V</given-names></name><name><surname>Kurecic-Filipovic</surname><given-names>S</given-names></name><name><surname>Babic-Erceg</surname><given-names>A</given-names></name><name><surname>Listes</surname><given-names>E</given-names></name><name><surname>Stevanovic</surname><given-names>V</given-names></name><name><surname>Gjenero-Margan</surname><given-names>I</given-names></name><name><surname>Savini</surname><given-names>G</given-names></name></person-group><article-title>First evidence of simultaneous occurrence of West Nile virus and Usutu virus neuroinvasive disease in humans in Croatia during the 2013 outbreak</article-title><source>Infection</source><year>2014</year><volume>42</volume><fpage>689</fpage><lpage>695</lpage><pub-id pub-id-type="pmid">24793998</pub-id></element-citation></ref><ref id="B115"><label>115</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santini</surname><given-names>M</given-names></name><name><surname>Vilibic-Cavlek</surname><given-names>T</given-names></name><name><surname>Barsic</surname><given-names>B</given-names></name><name><surname>Barbic</surname><given-names>L</given-names></name><name><surname>Savic</surname><given-names>V</given-names></name><name><surname>Stevanovic</surname><given-names>V</given-names></name><name><surname>Listes</surname><given-names>E</given-names></name><name><surname>Di Gennaro</surname><given-names>A</given-names></name><name><surname>Savini</surname><given-names>G</given-names></name></person-group><article-title>First cases of human Usutu virus neuroinvasive infection in Croatia, August-September 2013: clinical and laboratory features</article-title><source>J Neurovirol</source><year>2015</year><volume>21</volume><fpage>92</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">25361698</pub-id></element-citation></ref><ref id="B116"><label>116</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vilibic-Cavlek</surname><given-names>T</given-names></name><name><surname>Savic</surname><given-names>V</given-names></name><name><surname>Sabadi</surname><given-names>D</given-names></name><name><surname>Peric</surname><given-names>L</given-names></name><name><surname>Barbic</surname><given-names>L</given-names></name><name><surname>Klobucar</surname><given-names>A</given-names></name><name><surname>Miklausic</surname><given-names>B</given-names></name><name><surname>Tabain</surname><given-names>I</given-names></name><name><surname>Santini</surname><given-names>M</given-names></name><name><surname>Vucelja</surname><given-names>M</given-names></name><name><surname>Dvorski</surname><given-names>E</given-names></name><name><surname>Butigan</surname><given-names>T</given-names></name><name><surname>Kolaric-Sviben</surname><given-names>G</given-names></name><name><surname>Potocnik-Hunjadi</surname><given-names>T</given-names></name><name><surname>Balenovic</surname><given-names>M</given-names></name><name><surname>Bogdanic</surname><given-names>M</given-names></name><name><surname>Andric</surname><given-names>Z</given-names></name><name><surname>Stevanovic</surname><given-names>V</given-names></name><name><surname>Capak</surname><given-names>K</given-names></name><name><surname>Balicevic</surname><given-names>M</given-names></name><name><surname>Listes</surname><given-names>E</given-names></name><name><surname>Savini</surname><given-names>G</given-names></name></person-group><article-title>Prevalence and molecular epidemiology of West Nile and Usutu virus infections in Croatia in the &#x0201c;One Health&#x0201d; context, 2018</article-title><source>Transbound Emerg Dis</source><year>2019</year><volume>66</volume><fpage>1946</fpage><lpage>1957</lpage><pub-id pub-id-type="pmid">31067011</pub-id></element-citation></ref><ref id="B117"><label>117</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pacenti</surname><given-names>M</given-names></name><name><surname>Sinigaglia</surname><given-names>A</given-names></name><name><surname>Martello</surname><given-names>T</given-names></name><name><surname>De Rui</surname><given-names>ME</given-names></name><name><surname>Franchin</surname><given-names>E</given-names></name><name><surname>Pagni</surname><given-names>S</given-names></name><name><surname>Peta</surname><given-names>E</given-names></name><name><surname>Riccetti</surname><given-names>S</given-names></name><name><surname>Milani</surname><given-names>A</given-names></name><name><surname>Montarsi</surname><given-names>F</given-names></name><name><surname>Capelli</surname><given-names>G</given-names></name><name><surname>Doroldi</surname><given-names>CG</given-names></name><name><surname>Bigolin</surname><given-names>F</given-names></name><name><surname>Santelli</surname><given-names>L</given-names></name><name><surname>Nardetto</surname><given-names>L</given-names></name><name><surname>Zoccarato</surname><given-names>M</given-names></name><name><surname>Barzon</surname><given-names>L</given-names></name></person-group><article-title>Clinical and virological findings in patients with Usutu virus infection, northern Italy, 2018</article-title><source>Euro Surveill</source><year>2019</year><volume>24</volume></element-citation></ref><ref id="B118"><label>118</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pecorari</surname><given-names>M</given-names></name><name><surname>Longo</surname><given-names>G</given-names></name><name><surname>Gennari</surname><given-names>W</given-names></name><name><surname>Grottola</surname><given-names>A</given-names></name><name><surname>Sabbatini</surname><given-names>A</given-names></name><name><surname>Tagliazucchi</surname><given-names>S</given-names></name><name><surname>Savini</surname><given-names>G</given-names></name><name><surname>Monaco</surname><given-names>F</given-names></name><name><surname>Simone</surname><given-names>M</given-names></name><name><surname>Lelli</surname><given-names>R</given-names></name><name><surname>Rumpianesi</surname><given-names>F</given-names></name></person-group><article-title>First human case of Usutu virus neuroinvasive infection, Italy, August-September 2009</article-title><source>Euro Surveill</source><year>2009</year><volume>14</volume></element-citation></ref><ref id="B119"><label>119</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagy</surname><given-names>A</given-names></name><name><surname>Mezei</surname><given-names>E</given-names></name><name><surname>Nagy</surname><given-names>O</given-names></name><name><surname>Bakonyi</surname><given-names>T</given-names></name><name><surname>Csonka</surname><given-names>N</given-names></name><name><surname>Kaposi</surname><given-names>M</given-names></name><name><surname>Koroknai</surname><given-names>A</given-names></name><name><surname>Szomor</surname><given-names>K</given-names></name><name><surname>Rig&#x000f3;</surname><given-names>Z</given-names></name><name><surname>Moln&#x000e1;r</surname><given-names>Z</given-names></name><name><surname>D&#x000e1;nielisz</surname><given-names>&#x000c1;, Tak&#x000e1;cs M</given-names></name></person-group><article-title>Extraordinary increase in West Nile virus cases and first confirmed human Usutu virus infection in Hungary, 2018</article-title><source>Euro Surveill</source><year>2019</year><volume>24</volume></element-citation></ref><ref id="B120"><label>120</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simonin</surname><given-names>Y</given-names></name><name><surname>Sillam</surname><given-names>O</given-names></name><name><surname>Carles</surname><given-names>MJ</given-names></name><name><surname>Gutierrez</surname><given-names>S</given-names></name><name><surname>Gil</surname><given-names>P</given-names></name><name><surname>Constant</surname><given-names>O</given-names></name><name><surname>Martin</surname><given-names>MF</given-names></name><name><surname>Girard</surname><given-names>G</given-names></name><name><surname>Van de Perre</surname><given-names>P</given-names></name><name><surname>Salinas</surname><given-names>S</given-names></name><name><surname>Leparc-Goffart</surname><given-names>I</given-names></name><name><surname>Foulongne</surname><given-names>V</given-names></name></person-group><article-title>Human Usutu Virus Infection with Atypical Neurologic Presentation, Montpellier, France, 2016</article-title><source>Emerg Infect Dis</source><year>2018</year><volume>24</volume><fpage>875</fpage><lpage>878</lpage><pub-id pub-id-type="pmid">29664365</pub-id></element-citation></ref><ref id="B121"><label>121</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavrini</surname><given-names>F</given-names></name><name><surname>Gaibani</surname><given-names>P</given-names></name><name><surname>Longo</surname><given-names>G</given-names></name><name><surname>Pierro</surname><given-names>AM</given-names></name><name><surname>Rossini</surname><given-names>G</given-names></name><name><surname>Bonilauri</surname><given-names>P</given-names></name><name><surname>Gerunda</surname><given-names>GE</given-names></name><name><surname>Di Benedetto</surname><given-names>F</given-names></name><name><surname>Pasetto</surname><given-names>A</given-names></name><name><surname>Girardis</surname><given-names>M</given-names></name><name><surname>Dottori</surname><given-names>M</given-names></name><name><surname>Landini</surname><given-names>MP</given-names></name><name><surname>Sambri</surname><given-names>V</given-names></name></person-group><article-title>Usutu virus infection in a patient who underwent orthotropic liver transplantation, Italy, August-September 2009</article-title><source>Euro Surveill</source><year>2009</year><volume>14</volume></element-citation></ref><ref id="B122"><label>122</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morens</surname><given-names>DM</given-names></name><name><surname>Folkers</surname><given-names>GK</given-names></name><name><surname>Fauci</surname><given-names>AS</given-names></name></person-group><article-title>Eastern Equine Encephalitis Virus - Another Emergent Arbovirus in the United States</article-title><source>N Engl J Med</source><year>2019</year><volume>381</volume><fpage>1989</fpage><lpage>1992</lpage><pub-id pub-id-type="pmid">31747726</pub-id></element-citation></ref><ref id="B123"><label>123</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindsey</surname><given-names>NP</given-names></name><name><surname>Staples</surname><given-names>JE</given-names></name><name><surname>Fischer</surname><given-names>M</given-names></name></person-group><article-title>Eastern Equine Encephalitis Virus in the United States, 2003-2016</article-title><source>Am J Trop Med Hyg</source><year>2018</year><volume>98</volume><fpage>1472</fpage><lpage>1477</lpage><pub-id pub-id-type="pmid">29557336</pub-id></element-citation></ref><ref id="B124"><label>124</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pouch</surname><given-names>SM</given-names></name><name><surname>Katugaha</surname><given-names>SB</given-names></name><name><surname>Shieh</surname><given-names>WJ</given-names></name><name><surname>Annambhotla</surname><given-names>P</given-names></name><name><surname>Walker</surname><given-names>WL</given-names></name><name><surname>Basavaraju</surname><given-names>SV</given-names></name><name><surname>Jones</surname><given-names>J</given-names></name><name><surname>Huynh</surname><given-names>T</given-names></name><name><surname>Reagan-Steiner</surname><given-names>S</given-names></name><name><surname>Bhatnagar</surname><given-names>J</given-names></name><name><surname>Grimm</surname><given-names>K</given-names></name><name><surname>Stramer</surname><given-names>SL</given-names></name><name><surname>Gabel</surname><given-names>J</given-names></name><name><surname>Lyon</surname><given-names>GM</given-names></name><name><surname>Mehta</surname><given-names>AK</given-names></name><name><surname>Kandiah</surname><given-names>P</given-names></name><name><surname>Neujahr</surname><given-names>DC</given-names></name><name><surname>Javidfar</surname><given-names>J</given-names></name><name><surname>Subramanian</surname><given-names>RM</given-names></name><name><surname>Parekh</surname><given-names>SM</given-names></name><name><surname>Shah</surname><given-names>P</given-names></name><name><surname>Cooper</surname><given-names>L</given-names></name><name><surname>Psotka</surname><given-names>MA</given-names></name><name><surname>Radcliffe</surname><given-names>R</given-names></name><name><surname>Williams</surname><given-names>C</given-names></name><name><surname>Zaki</surname><given-names>SR</given-names></name><name><surname>Staples</surname><given-names>JE</given-names></name><name><surname>Fischer</surname><given-names>M</given-names></name><name><surname>Panella</surname><given-names>AJ</given-names></name><name><surname>Lanciotti</surname><given-names>RS</given-names></name><name><surname>Laven</surname><given-names>JJ</given-names></name><name><surname>Kosoy</surname><given-names>O</given-names></name><name><surname>Rabe</surname><given-names>IB</given-names></name><name><surname>Gould</surname><given-names>CV</given-names></name></person-group><collab>Eastern Equine Encephalitis Virus Transplant Transmission Investigation Team</collab><article-title>Transmission of Eastern Equine Encephalitis Virus From an Organ Donor to 3 Transplant Recipients</article-title><source>Clin Infect Dis</source><year>2019</year><volume>69</volume><fpage>450</fpage><lpage>458</lpage><pub-id pub-id-type="pmid">30371754</pub-id></element-citation></ref><ref id="B125"><label>125</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steverding</surname><given-names>D</given-names></name></person-group><article-title>The history of leishmaniasis</article-title><source>Parasit Vectors</source><year>2017</year><volume>10</volume><fpage>82</fpage><pub-id pub-id-type="pmid">28202044</pub-id></element-citation></ref><ref id="B126"><label>126</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antinori</surname><given-names>S</given-names></name><name><surname>Schifanella</surname><given-names>L</given-names></name><name><surname>Corbellino</surname><given-names>M</given-names></name></person-group><article-title>Leishmaniasis: new insights from an old and neglected disease</article-title><source>Eur J Clin Microbiol Infect Dis</source><year>2012</year><volume>31</volume><fpage>109</fpage><lpage>118</lpage><pub-id pub-id-type="pmid">21533874</pub-id></element-citation></ref><ref id="B127"><label>127</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Griensven</surname><given-names>J</given-names></name><name><surname>Diro</surname><given-names>E</given-names></name></person-group><article-title>Visceral Leishmaniasis: Recent Advances in Diagnostics and Treatment Regimens</article-title><source>Infect Dis Clin North Am</source><year>2019</year><volume>33</volume><fpage>79</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">30712769</pub-id></element-citation></ref><ref id="B128"><label>128</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antinori</surname><given-names>S</given-names></name><name><surname>Cascio</surname><given-names>A</given-names></name><name><surname>Parravicini</surname><given-names>C</given-names></name><name><surname>Bianchi</surname><given-names>R</given-names></name><name><surname>Corbellino</surname><given-names>M</given-names></name></person-group><article-title>Leishmaniasis among organ transplant recipients</article-title><source>Lancet Infect Dis</source><year>2008</year><volume>8</volume><fpage>191</fpage><lpage>199</lpage><pub-id pub-id-type="pmid">18291340</pub-id></element-citation></ref><ref id="B129"><label>129</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clemente</surname><given-names>WT</given-names></name><name><surname>Mour&#x000e3;o</surname><given-names>PHO</given-names></name><name><surname>Lopez-Medrano</surname><given-names>F</given-names></name><name><surname>Schwartz</surname><given-names>BS</given-names></name><name><surname>Garc&#x000ed;a-Donoso</surname><given-names>C</given-names></name><name><surname>Torre-Cisneros</surname><given-names>J</given-names></name></person-group><article-title>Visceral and Cutaneous Leishmaniasis Recommendations for Solid Organ Transplant Recipients and Donors</article-title><source>Transplantation</source><year>2018</year><volume>102</volume><fpage>S8</fpage><lpage>S15</lpage><pub-id pub-id-type="pmid">29381573</pub-id></element-citation></ref><ref id="B130"><label>130</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clemente</surname><given-names>W</given-names></name><name><surname>Vidal</surname><given-names>E</given-names></name><name><surname>Gir&#x000e3;o</surname><given-names>E</given-names></name><name><surname>Ramos</surname><given-names>AS</given-names></name><name><surname>Govedic</surname><given-names>F</given-names></name><name><surname>Merino</surname><given-names>E</given-names></name><name><surname>Mu&#x000f1;oz</surname><given-names>P</given-names></name><name><surname>Sab&#x000e9;</surname><given-names>N</given-names></name><name><surname>Cervera</surname><given-names>C</given-names></name><name><surname>Cota</surname><given-names>GF</given-names></name><name><surname>Cordero</surname><given-names>E</given-names></name><name><surname>Mena</surname><given-names>A</given-names></name><name><surname>Montejo</surname><given-names>M</given-names></name><name><surname>L&#x000f3;pez-Medrano</surname><given-names>F</given-names></name><name><surname>Aguado</surname><given-names>JM</given-names></name><name><surname>Fernandes</surname><given-names>P</given-names></name><name><surname>Valerio</surname><given-names>M</given-names></name><name><surname>Carratal&#x000e1;</surname><given-names>J</given-names></name><name><surname>Moreno</surname><given-names>A</given-names></name><name><surname>Oliveira</surname><given-names>J</given-names></name><name><surname>Mour&#x000e3;o</surname><given-names>PH</given-names></name><name><surname>Torre-Cisneros</surname><given-names>J</given-names></name></person-group><article-title>Risk factors, clinical features and outcomes of visceral leishmaniasis in solid-organ transplant recipients: a retrospective multicenter case-control study</article-title><source>Clin Microbiol Infect</source><year>2015</year><volume>21</volume><fpage>89</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">25636932</pub-id></element-citation></ref><ref id="B131"><label>131</label><element-citation publication-type="journal"><collab>European Association for the Study of the Liver</collab><article-title>EASL Clinical Practice Guidelines on hepatitis E virus infection</article-title><source>J Hepatol</source><year>2018</year><volume>68</volume><fpage>1256</fpage><lpage>1271</lpage><pub-id pub-id-type="pmid">29609832</pub-id></element-citation></ref><ref id="B132"><label>132</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blasco-Perrin</surname><given-names>H</given-names></name><name><surname>Madden</surname><given-names>RG</given-names></name><name><surname>Stanley</surname><given-names>A</given-names></name><name><surname>Crossan</surname><given-names>C</given-names></name><name><surname>Hunter</surname><given-names>JG</given-names></name><name><surname>Vine</surname><given-names>L</given-names></name><name><surname>Lane</surname><given-names>K</given-names></name><name><surname>Devooght-Johnson</surname><given-names>N</given-names></name><name><surname>Mclaughlin</surname><given-names>C</given-names></name><name><surname>Petrik</surname><given-names>J</given-names></name><name><surname>Stableforth</surname><given-names>B</given-names></name><name><surname>Hussaini</surname><given-names>H</given-names></name><name><surname>Phillips</surname><given-names>M</given-names></name><name><surname>Mansuy</surname><given-names>JM</given-names></name><name><surname>Forrest</surname><given-names>E</given-names></name><name><surname>Izopet</surname><given-names>J</given-names></name><name><surname>Blatchford</surname><given-names>O</given-names></name><name><surname>Scobie</surname><given-names>L</given-names></name><name><surname>Peron</surname><given-names>JM</given-names></name><name><surname>Dalton</surname><given-names>HR</given-names></name></person-group><article-title>Hepatitis E virus in patients with decompensated chronic liver disease: a prospective UK/French study</article-title><source>Aliment Pharmacol Ther</source><year>2015</year><volume>42</volume><fpage>574</fpage><lpage>581</lpage><pub-id pub-id-type="pmid">26174470</pub-id></element-citation></ref><ref id="B133"><label>133</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamar</surname><given-names>N</given-names></name><name><surname>Selves</surname><given-names>J</given-names></name><name><surname>Mansuy</surname><given-names>JM</given-names></name><name><surname>Ouezzani</surname><given-names>L</given-names></name><name><surname>P&#x000e9;ron</surname><given-names>JM</given-names></name><name><surname>Guitard</surname><given-names>J</given-names></name><name><surname>Cointault</surname><given-names>O</given-names></name><name><surname>Esposito</surname><given-names>L</given-names></name><name><surname>Abravanel</surname><given-names>F</given-names></name><name><surname>Danjoux</surname><given-names>M</given-names></name><name><surname>Durand</surname><given-names>D</given-names></name><name><surname>Vinel</surname><given-names>JP</given-names></name><name><surname>Izopet</surname><given-names>J</given-names></name><name><surname>Rostaing</surname><given-names>L</given-names></name></person-group><article-title>Hepatitis E virus and chronic hepatitis in organ-transplant recipients</article-title><source>N Engl J Med</source><year>2008</year><volume>358</volume><fpage>811</fpage><lpage>817</lpage><pub-id pub-id-type="pmid">18287603</pub-id></element-citation></ref><ref id="B134"><label>134</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamar</surname><given-names>N</given-names></name><name><surname>Garrouste</surname><given-names>C</given-names></name><name><surname>Haagsma</surname><given-names>EB</given-names></name><name><surname>Garrigue</surname><given-names>V</given-names></name><name><surname>Pischke</surname><given-names>S</given-names></name><name><surname>Chauvet</surname><given-names>C</given-names></name><name><surname>Dumortier</surname><given-names>J</given-names></name><name><surname>Cannesson</surname><given-names>A</given-names></name><name><surname>Cassuto-Viguier</surname><given-names>E</given-names></name><name><surname>Thervet</surname><given-names>E</given-names></name><name><surname>Conti</surname><given-names>F</given-names></name><name><surname>Lebray</surname><given-names>P</given-names></name><name><surname>Dalton</surname><given-names>HR</given-names></name><name><surname>Santella</surname><given-names>R</given-names></name><name><surname>Kanaan</surname><given-names>N</given-names></name><name><surname>Essig</surname><given-names>M</given-names></name><name><surname>Mousson</surname><given-names>C</given-names></name><name><surname>Radenne</surname><given-names>S</given-names></name><name><surname>Roque-Afonso</surname><given-names>AM</given-names></name><name><surname>Izopet</surname><given-names>J</given-names></name><name><surname>Rostaing</surname><given-names>L</given-names></name></person-group><article-title>Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants</article-title><source>Gastroenterology</source><year>2011</year><volume>140</volume><fpage>1481</fpage><lpage>1489</lpage><pub-id pub-id-type="pmid">21354150</pub-id></element-citation></ref><ref id="B135"><label>135</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woolson</surname><given-names>KL</given-names></name><name><surname>Forbes</surname><given-names>A</given-names></name><name><surname>Vine</surname><given-names>L</given-names></name><name><surname>Beynon</surname><given-names>L</given-names></name><name><surname>McElhinney</surname><given-names>L</given-names></name><name><surname>Panayi</surname><given-names>V</given-names></name><name><surname>Hunter</surname><given-names>JG</given-names></name><name><surname>Madden</surname><given-names>RG</given-names></name><name><surname>Glasgow</surname><given-names>T</given-names></name><name><surname>Kotecha</surname><given-names>A</given-names></name><name><surname>Dalton</surname><given-names>HC</given-names></name><name><surname>Mihailescu</surname><given-names>L</given-names></name><name><surname>Warshow</surname><given-names>U</given-names></name><name><surname>Hussaini</surname><given-names>HS</given-names></name><name><surname>Palmer</surname><given-names>J</given-names></name><name><surname>Mclean</surname><given-names>BN</given-names></name><name><surname>Haywood</surname><given-names>B</given-names></name><name><surname>Bendall</surname><given-names>RP</given-names></name><name><surname>Dalton</surname><given-names>HR</given-names></name></person-group><article-title>Extra-hepatic manifestations of autochthonous hepatitis E infection</article-title><source>Aliment Pharmacol Ther</source><year>2014</year><volume>40</volume><fpage>1282</fpage><lpage>1291</lpage><pub-id pub-id-type="pmid">25303615</pub-id></element-citation></ref><ref id="B136"><label>136</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamar</surname><given-names>N</given-names></name><name><surname>Weclawiak</surname><given-names>H</given-names></name><name><surname>Guilbeau-Frugier</surname><given-names>C</given-names></name><name><surname>Legrand-Abravanel</surname><given-names>F</given-names></name><name><surname>Cointault</surname><given-names>O</given-names></name><name><surname>Ribes</surname><given-names>D</given-names></name><name><surname>Esposito</surname><given-names>L</given-names></name><name><surname>Cardeau-Desangles</surname><given-names>I</given-names></name><name><surname>Guitard</surname><given-names>J</given-names></name><name><surname>Sallusto</surname><given-names>F</given-names></name><name><surname>Muscari</surname><given-names>F</given-names></name><name><surname>Peron</surname><given-names>JM</given-names></name><name><surname>Alric</surname><given-names>L</given-names></name><name><surname>Izopet</surname><given-names>J</given-names></name><name><surname>Rostaing</surname><given-names>L</given-names></name></person-group><article-title>Hepatitis E virus and the kidney in solid-organ transplant patients</article-title><source>Transplantation</source><year>2012</year><volume>93</volume><fpage>617</fpage><lpage>623</lpage><pub-id pub-id-type="pmid">22298032</pub-id></element-citation></ref><ref id="B137"><label>137</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamar</surname><given-names>N</given-names></name><name><surname>Abravanel</surname><given-names>F</given-names></name><name><surname>Behrendt</surname><given-names>P</given-names></name><name><surname>Hofmann</surname><given-names>J, Pageaux GP, Barbet C, Moal V, Couzi L, Horvatits T, De Man RA, Cassuto E, Elsharkawy AM, Riezebos-Brilman A, Scemla A, Hillaire S, Donnelly MC, Radenne S, Sayegh J, Garrouste C, Dumortier J, Glowaki F, Matignon M, Coilly A, Figueres L, Mousson C, Minello A, Dharancy S, Rerolle JP, Lebray P, Etienne I, Perrin P, Choi M, Marion O, Izopet J, Hepatitis E Virus Ribavirin Study Group</given-names></name></person-group><article-title>Ribavirin for Hepatitis E Virus Infection After Organ Transplantation: A Large European Retrospective Multicenter Study</article-title><source>Clinical Infectious Diseases</source><year>2019</year><pub-id pub-id-type="doi">10.1093/cid/ciz953</pub-id></element-citation></ref><ref id="B138"><label>138</label><element-citation publication-type="webpage"><collab>World Health Organisation (WHO)</collab><article-title>Rabies Bulletin - Europe</article-title><comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.who-rabies-bulletin.org/site-page/epidemiology-rabies">https://www.who-rabies-bulletin.org/site-page/epidemiology-rabies</ext-link></comment></element-citation></ref><ref id="B139"><label>139</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houff</surname><given-names>SA</given-names></name><name><surname>Burton</surname><given-names>RC</given-names></name><name><surname>Wilson</surname><given-names>RW</given-names></name><name><surname>Henson</surname><given-names>TE</given-names></name><name><surname>London</surname><given-names>WT</given-names></name><name><surname>Baer</surname><given-names>GM</given-names></name><name><surname>Anderson</surname><given-names>LJ</given-names></name><name><surname>Winkler</surname><given-names>WG</given-names></name><name><surname>Madden</surname><given-names>DL</given-names></name><name><surname>Sever</surname><given-names>JL</given-names></name></person-group><article-title>Human-to-human transmission of rabies virus by corneal transplant</article-title><source>N Engl J Med</source><year>1979</year><volume>300</volume><fpage>603</fpage><lpage>604</lpage><pub-id pub-id-type="pmid">368632</pub-id></element-citation></ref><ref id="B140"><label>140</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Javadi</surname><given-names>MA</given-names></name><name><surname>Fayaz</surname><given-names>A</given-names></name><name><surname>Mirdehghan</surname><given-names>SA</given-names></name><name><surname>Ainollahi</surname><given-names>B</given-names></name></person-group><article-title>Transmission of rabies by corneal graft</article-title><source>Cornea</source><year>1996</year><volume>15</volume><fpage>431</fpage><lpage>433</lpage><pub-id pub-id-type="pmid">8776570</pub-id></element-citation></ref><ref id="B141"><label>141</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maier</surname><given-names>T</given-names></name><name><surname>Schwarting</surname><given-names>A</given-names></name><name><surname>Mauer</surname><given-names>D</given-names></name><name><surname>Ross</surname><given-names>RS</given-names></name><name><surname>Martens</surname><given-names>A</given-names></name><name><surname>Kliem</surname><given-names>V</given-names></name><name><surname>Wahl</surname><given-names>J</given-names></name><name><surname>Panning</surname><given-names>M</given-names></name><name><surname>Baumgarte</surname><given-names>S</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>T</given-names></name><name><surname>Pfefferle</surname><given-names>S</given-names></name><name><surname>Ebel</surname><given-names>H</given-names></name><name><surname>Schmidt</surname><given-names>J</given-names></name><name><surname>Tenner-Racz</surname><given-names>K</given-names></name><name><surname>Racz</surname><given-names>P</given-names></name><name><surname>Schmid</surname><given-names>M</given-names></name><name><surname>Str&#x000fc;ber</surname><given-names>M</given-names></name><name><surname>Wolters</surname><given-names>B</given-names></name><name><surname>Gotthardt</surname><given-names>D</given-names></name><name><surname>Bitz</surname><given-names>F</given-names></name><name><surname>Frisch</surname><given-names>L</given-names></name><name><surname>Pfeiffer</surname><given-names>N</given-names></name><name><surname>Fickenscher</surname><given-names>H</given-names></name><name><surname>Sauer</surname><given-names>P</given-names></name><name><surname>Rupprecht</surname><given-names>CE</given-names></name><name><surname>Roggendorf</surname><given-names>M</given-names></name><name><surname>Haverich</surname><given-names>A</given-names></name><name><surname>Galle</surname><given-names>P</given-names></name><name><surname>Hoyer</surname><given-names>J</given-names></name><name><surname>Drosten</surname><given-names>C</given-names></name></person-group><article-title>Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus</article-title><source>Clin Infect Dis</source><year>2010</year><volume>50</volume><fpage>1112</fpage><lpage>1119</lpage><pub-id pub-id-type="pmid">20205588</pub-id></element-citation></ref><ref id="B142"><label>142</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vetter</surname><given-names>JM</given-names></name><name><surname>Frisch</surname><given-names>L</given-names></name><name><surname>Drosten</surname><given-names>C</given-names></name><name><surname>Ross</surname><given-names>RS</given-names></name><name><surname>Roggendorf</surname><given-names>M</given-names></name><name><surname>Wolters</surname><given-names>B</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>T</given-names></name><name><surname>Dick</surname><given-names>HB</given-names></name><name><surname>Pfeiffer</surname><given-names>N</given-names></name></person-group><article-title>Survival after transplantation of corneas from a rabies-infected donor</article-title><source>Cornea</source><year>2011</year><volume>30</volume><fpage>241</fpage><lpage>244</lpage><pub-id pub-id-type="pmid">20847660</pub-id></element-citation></ref><ref id="B143"><label>143</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srinivasan</surname><given-names>A</given-names></name><name><surname>Burton</surname><given-names>EC</given-names></name><name><surname>Kuehnert</surname><given-names>MJ</given-names></name><name><surname>Rupprecht</surname><given-names>C</given-names></name><name><surname>Sutker</surname><given-names>WL</given-names></name><name><surname>Ksiazek</surname><given-names>TG</given-names></name><name><surname>Paddock</surname><given-names>CD</given-names></name><name><surname>Guarner</surname><given-names>J</given-names></name><name><surname>Shieh</surname><given-names>WJ</given-names></name><name><surname>Goldsmith</surname><given-names>C</given-names></name><name><surname>Hanlon</surname><given-names>CA</given-names></name><name><surname>Zoretic</surname><given-names>J</given-names></name><name><surname>Fischbach</surname><given-names>B</given-names></name><name><surname>Niezgoda</surname><given-names>M</given-names></name><name><surname>El-Feky</surname><given-names>WH</given-names></name><name><surname>Orciari</surname><given-names>L</given-names></name><name><surname>Sanchez</surname><given-names>EQ</given-names></name><name><surname>Likos</surname><given-names>A</given-names></name><name><surname>Klintmalm</surname><given-names>GB</given-names></name><name><surname>Cardo</surname><given-names>D</given-names></name><name><surname>LeDuc</surname><given-names>J</given-names></name><name><surname>Chamberland</surname><given-names>ME</given-names></name><name><surname>Jernigan</surname><given-names>DB</given-names></name><name><surname>Zaki</surname><given-names>SR</given-names></name></person-group><collab>Rabies in Transplant Recipients Investigation Team</collab><article-title>Transmission of rabies virus from an organ donor to four transplant recipients</article-title><source>N Engl J Med</source><year>2005</year><volume>352</volume><fpage>1103</fpage><lpage>1111</lpage><pub-id pub-id-type="pmid">15784663</pub-id></element-citation></ref><ref id="B144"><label>144</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vora</surname><given-names>NM</given-names></name><name><surname>Basavaraju</surname><given-names>SV</given-names></name><name><surname>Feldman</surname><given-names>KA</given-names></name><name><surname>Paddock</surname><given-names>CD</given-names></name><name><surname>Orciari</surname><given-names>L</given-names></name><name><surname>Gitterman</surname><given-names>S</given-names></name><name><surname>Griese</surname><given-names>S</given-names></name><name><surname>Wallace</surname><given-names>RM</given-names></name><name><surname>Said</surname><given-names>M</given-names></name><name><surname>Blau</surname><given-names>DM</given-names></name><name><surname>Selvaggi</surname><given-names>G</given-names></name><name><surname>Velasco-Villa</surname><given-names>A</given-names></name><name><surname>Ritter</surname><given-names>J</given-names></name><name><surname>Yager</surname><given-names>P</given-names></name><name><surname>Kresch</surname><given-names>A</given-names></name><name><surname>Niezgoda</surname><given-names>M</given-names></name><name><surname>Blanton</surname><given-names>J</given-names></name><name><surname>Stosor</surname><given-names>V</given-names></name><name><surname>Falta</surname><given-names>EM</given-names></name><name><surname>Lyon</surname><given-names>GM</given-names><suffix>3rd</suffix></name><name><surname>Zembower</surname><given-names>T</given-names></name><name><surname>Kuzmina</surname><given-names>N</given-names></name><name><surname>Rohatgi</surname><given-names>PK</given-names></name><name><surname>Recuenco</surname><given-names>S</given-names></name><name><surname>Zaki</surname><given-names>S</given-names></name><name><surname>Damon</surname><given-names>I</given-names></name><name><surname>Franka</surname><given-names>R</given-names></name><name><surname>Kuehnert</surname><given-names>MJ</given-names></name></person-group><collab>Transplant-Associated Rabies Virus Transmission Investigation Team</collab><article-title>Raccoon rabies virus variant transmission through solid organ transplantation</article-title><source>JAMA</source><year>2013</year><volume>310</volume><fpage>398</fpage><lpage>407</lpage><pub-id pub-id-type="pmid">23917290</pub-id></element-citation></ref><ref id="B145"><label>145</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Tian</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>L</given-names></name><name><surname>Sun</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Qiu</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name></person-group><article-title>Transmission of rabies through solid organ transplantation: a notable problem in China</article-title><source>BMC Infect Dis</source><year>2018</year><volume>18</volume><fpage>273</fpage><pub-id pub-id-type="pmid">29898712</pub-id></element-citation></ref><ref id="B146"><label>146</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Luo</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Yao</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>T</given-names></name></person-group><article-title>Rabies Virus Transmission in Solid Organ Transplantation, China, 2015-2016</article-title><source>Emerg Infect Dis</source><year>2017</year><volume>23</volume><fpage>1600</fpage><lpage>1602</lpage><pub-id pub-id-type="pmid">28820377</pub-id></element-citation></ref><ref id="B147"><label>147</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saeed</surname><given-names>B</given-names></name><name><surname>Al-Mousawi</surname><given-names>M</given-names></name></person-group><article-title>Rabies Acquired Through Kidney Transplantation in a Child: A Case Report</article-title><source>Exp Clin Transplant</source><year>2017</year><volume>15</volume><fpage>355</fpage><lpage>357</lpage><pub-id pub-id-type="pmid">28411355</pub-id></element-citation></ref><ref id="B148"><label>148</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amman</surname><given-names>BR</given-names></name><name><surname>Pavlin</surname><given-names>BI</given-names></name><name><surname>Albari&#x000f1;o</surname><given-names>CG</given-names></name><name><surname>Comer</surname><given-names>JA</given-names></name><name><surname>Erickson</surname><given-names>BR</given-names></name><name><surname>Oliver</surname><given-names>JB</given-names></name><name><surname>Sealy</surname><given-names>TK</given-names></name><name><surname>Vincent</surname><given-names>MJ</given-names></name><name><surname>Nichol</surname><given-names>ST</given-names></name><name><surname>Paddock</surname><given-names>CD</given-names></name><name><surname>Tumpey</surname><given-names>AJ</given-names></name><name><surname>Wagoner</surname><given-names>KD</given-names></name><name><surname>Glauer</surname><given-names>RD</given-names></name><name><surname>Smith</surname><given-names>KA</given-names></name><name><surname>Winpisinger</surname><given-names>KA</given-names></name><name><surname>Parsely</surname><given-names>MS</given-names></name><name><surname>Wyrick</surname><given-names>P</given-names></name><name><surname>Hannafin</surname><given-names>CH</given-names></name><name><surname>Bandy</surname><given-names>U</given-names></name><name><surname>Zaki</surname><given-names>S</given-names></name><name><surname>Rollin</surname><given-names>PE</given-names></name><name><surname>Ksiazek</surname><given-names>TG</given-names></name></person-group><article-title>Pet rodents and fatal lymphocytic choriomeningitis in transplant patients</article-title><source>Emerg Infect Dis</source><year>2007</year><volume>13</volume><fpage>719</fpage><lpage>725</lpage><pub-id pub-id-type="pmid">17553250</pub-id></element-citation></ref><ref id="B149"><label>149</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Childs</surname><given-names>JE</given-names></name><name><surname>Klein</surname><given-names>SL</given-names></name><name><surname>Glass</surname><given-names>GE</given-names></name></person-group><article-title>A Case Study of Two Rodent-Borne Viruses: Not Always the Same Old Suspects</article-title><source>Front Ecol Evol</source><year>2019</year><volume>35</volume></element-citation></ref><ref id="B150"><label>150</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>SA</given-names></name><name><surname>Graham</surname><given-names>MB</given-names></name><name><surname>Kuehnert</surname><given-names>MJ</given-names></name><name><surname>Kotton</surname><given-names>CN</given-names></name><name><surname>Srinivasan</surname><given-names>A</given-names></name><name><surname>Marty</surname><given-names>FM</given-names></name><name><surname>Comer</surname><given-names>JA</given-names></name><name><surname>Guarner</surname><given-names>J</given-names></name><name><surname>Paddock</surname><given-names>CD</given-names></name><name><surname>DeMeo</surname><given-names>DL</given-names></name><name><surname>Shieh</surname><given-names>WJ</given-names></name><name><surname>Erickson</surname><given-names>BR</given-names></name><name><surname>Bandy</surname><given-names>U</given-names></name><name><surname>DeMaria</surname><given-names>A</given-names><suffix>Jr</suffix></name><name><surname>Davis</surname><given-names>JP</given-names></name><name><surname>Delmonico</surname><given-names>FL</given-names></name><name><surname>Pavlin</surname><given-names>B</given-names></name><name><surname>Likos</surname><given-names>A</given-names></name><name><surname>Vincent</surname><given-names>MJ</given-names></name><name><surname>Sealy</surname><given-names>TK</given-names></name><name><surname>Goldsmith</surname><given-names>CS</given-names></name><name><surname>Jernigan</surname><given-names>DB</given-names></name><name><surname>Rollin</surname><given-names>PE</given-names></name><name><surname>Packard</surname><given-names>MM</given-names></name><name><surname>Patel</surname><given-names>M</given-names></name><name><surname>Rowland</surname><given-names>C</given-names></name><name><surname>Helfand</surname><given-names>RF</given-names></name><name><surname>Nichol</surname><given-names>ST</given-names></name><name><surname>Fishman</surname><given-names>JA</given-names></name><name><surname>Ksiazek</surname><given-names>T</given-names></name><name><surname>Zaki</surname><given-names>SR</given-names></name></person-group><collab>LCMV in Transplant Recipients Investigation Team</collab><article-title>Transmission of lymphocytic choriomeningitis virus by organ transplantation</article-title><source>N Engl J Med</source><year>2006</year><volume>354</volume><fpage>2235</fpage><lpage>2249</lpage><pub-id pub-id-type="pmid">16723615</pub-id></element-citation></ref><ref id="B151"><label>151</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macneil</surname><given-names>A</given-names></name><name><surname>Str&#x000f6;her</surname><given-names>U</given-names></name><name><surname>Farnon</surname><given-names>E</given-names></name><name><surname>Campbell</surname><given-names>S</given-names></name><name><surname>Cannon</surname><given-names>D</given-names></name><name><surname>Paddock</surname><given-names>CD</given-names></name><name><surname>Drew</surname><given-names>CP</given-names></name><name><surname>Kuehnert</surname><given-names>M</given-names></name><name><surname>Knust</surname><given-names>B</given-names></name><name><surname>Gruenenfelder</surname><given-names>R</given-names></name><name><surname>Zaki</surname><given-names>SR</given-names></name><name><surname>Rollin</surname><given-names>PE</given-names></name><name><surname>Nichol</surname><given-names>ST</given-names></name></person-group><collab>LCMV Transplant Investigation Team</collab><article-title>Solid organ transplant-associated lymphocytic choriomeningitis, United States, 2011</article-title><source>Emerg Infect Dis</source><year>2012</year><volume>18</volume><fpage>1256</fpage><lpage>1262</lpage><pub-id pub-id-type="pmid">22839997</pub-id></element-citation></ref><ref id="B152"><label>152</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanveer</surname><given-names>F</given-names></name><name><surname>Younas</surname><given-names>M</given-names></name><name><surname>Fishbain</surname><given-names>J</given-names></name></person-group><article-title>Lymphocytic choriomeningitis virus meningoencephalitis in a renal transplant recipient following exposure to mice</article-title><source>Transpl Infect Dis</source><year>2018</year><volume>20</volume><fpage>e13013</fpage><pub-id pub-id-type="pmid">30325104</pub-id></element-citation></ref><ref id="B153"><label>153</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto-Ferreira</surname><given-names>F</given-names></name><name><surname>Caldart</surname><given-names>ET</given-names></name><name><surname>Pasquali</surname><given-names>AKS</given-names></name><name><surname>Mitsuka-Bregan&#x000f3;</surname><given-names>R</given-names></name><name><surname>Freire</surname><given-names>RL</given-names></name><name><surname>Navarro</surname><given-names>IT</given-names></name></person-group><article-title>Patterns of Transmission and Sources of Infection in Outbreaks of Human Toxoplasmosis</article-title><source>Emerg Infect Dis</source><year>2019</year><volume>25</volume><fpage>2177</fpage><lpage>2182</lpage><pub-id pub-id-type="pmid">31742524</pub-id></element-citation></ref><ref id="B154"><label>154</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robert-Gangneux</surname><given-names>F</given-names></name><name><surname>Dard&#x000e9;</surname><given-names>ML</given-names></name></person-group><article-title>Epidemiology of and diagnostic strategies for toxoplasmosis</article-title><source>Clin Microbiol Rev</source><year>2012</year><volume>25</volume><fpage>264</fpage><lpage>296</lpage><pub-id pub-id-type="pmid">22491772</pub-id></element-citation></ref><ref id="B155"><label>155</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pappas</surname><given-names>G</given-names></name><name><surname>Roussos</surname><given-names>N</given-names></name><name><surname>Falagas</surname><given-names>ME</given-names></name></person-group><article-title>Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis</article-title><source>Int J Parasitol</source><year>2009</year><volume>39</volume><fpage>1385</fpage><lpage>1394</lpage><pub-id pub-id-type="pmid">19433092</pub-id></element-citation></ref><ref id="B156"><label>156</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>LM</given-names></name><name><surname>Dubey</surname><given-names>JP</given-names></name></person-group><article-title>Toxoplasmosis: A history of clinical observations</article-title><source>Int J Parasitol</source><year>2009</year><volume>39</volume><fpage>895</fpage><lpage>901</lpage><pub-id pub-id-type="pmid">19217908</pub-id></element-citation></ref><ref id="B157"><label>157</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khurana</surname><given-names>S</given-names></name><name><surname>Batra</surname><given-names>N</given-names></name></person-group><article-title>Toxoplasmosis in organ transplant recipients: Evaluation, implication, and prevention</article-title><source>Trop Parasitol</source><year>2016</year><volume>6</volume><fpage>123</fpage><lpage>128</lpage><pub-id pub-id-type="pmid">27722100</pub-id></element-citation></ref><ref id="B158"><label>158</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robert-Gangneux</surname><given-names>F</given-names></name><name><surname>Meroni</surname><given-names>V, Dupont D, Botterel F, Garcia JMA, Brenier-Pinchart MP, Accoceberry I, Akan H, Abbate I, Boggian K, Bruschi F, Carratal&#x000e0; J, David M, Drgona L, Djurkovi&#x00107;-Djakovi&#x00107; O, Farinas MC, Genco F, Gkrania-Klotsas E, Groll AH, Guy E, Hirzel C, Khanna N, Kurt &#x000d6;, Junie LM, Lazzarotto T, Len O, Mueller NJ, Munoz P, Pana ZD, Roilides E, Stajner T, van Delden C, Villena I, Pelloux H, Manuel O</given-names></name></person-group><article-title>Toxoplasmosis in Transplant Recipients, Europe, 2010-2014</article-title><source>Emerg Infect Dis</source><year>2018</year><volume>24</volume><fpage>1497</fpage><lpage>1504</lpage><pub-id pub-id-type="pmid">30014843</pub-id></element-citation></ref></ref-list></back></article>